{
    "abstract": "With the discovery of P-glycoprotein (P-gp), it became evident that ABC-transporters play a vital role in bioavailability and toxicity of drugs. They prevent intracellular accumulation of toxic compounds, which renders them a major defense mechanism against xenotoxic compounds. Their expression in cells of all major barriers (intestine, blood-brain barrier, blood-placenta barrier) as well as in metabolic organs (liver, kidney) also explains their influence on the ADMET properties of drugs and drug candidates. Thus, in silico models for the prediction of the probability of a compound to interact with P-gp or analogous transporters are of high value in the early phase of the drug discovery process. Within this review, we highlight recent developments in the area, with a special focus on the molecular basis of drug-transporter interaction. In addition, with the recent availability of X-ray structures of several ABC-transporters, also structure-based design methods have been applied and will be addressed.",
    "bib_entries": {
        "bb0005": {
            "authors": [
                {
                    "first": "Vasilis",
                    "initial": "V.",
                    "last": "Vasiliou"
                },
                {
                    "first": "Konstandinos",
                    "initial": "K.",
                    "last": "Vasiliou"
                },
                {
                    "first": "Daniel W.",
                    "initial": "D.W.",
                    "last": "Nebert"
                }
            ],
            "firstpage": "281",
            "issn": "14797364",
            "lastpage": "290",
            "pmid": "19403462",
            "pub_year": 2009,
            "title": "Human ATP-binding cassette (ABC) transporter family.",
            "volume": "3"
        },
        "bb0010": {
            "authors": [
                {
                    "first": "Elizabeth J.",
                    "initial": "E.J.",
                    "last": "Tarling"
                },
                {
                    "first": "Thomas Q.de Aguiar",
                    "initial": "T.Q.d.A.",
                    "last": "Vallim"
                },
                {
                    "first": "Peter A.",
                    "initial": "P.A.",
                    "last": "Edwards"
                }
            ],
            "doi": "10.1016/j.tem.2013.01.006",
            "firstpage": "342",
            "issn": "10432760",
            "lastpage": "350",
            "pmid": "23415156",
            "pub_year": 2013,
            "title": "Role of ABC transporters in lipid transport and human disease",
            "volume": "24"
        },
        "bb0015": {
            "authors": [
                {
                    "first": "R. L.",
                    "initial": "R.L.",
                    "last": "Juliano"
                },
                {
                    "first": "V.",
                    "initial": "V.",
                    "last": "Ling"
                }
            ],
            "doi": "10.1016/0005-2736(76)90160-7",
            "firstpage": "152",
            "issn": "00052736",
            "lastpage": "162",
            "pmid": "990323",
            "pub_year": 1976,
            "title": "A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants",
            "volume": "455"
        },
        "bb0020": {
            "authors": [
                {
                    "first": "Mitali",
                    "initial": "M.",
                    "last": "Chatterjee"
                },
                {
                    "first": "Craig N.",
                    "initial": "C.N.",
                    "last": "Robson"
                },
                {
                    "first": "Adrian L.",
                    "initial": "A.L.",
                    "last": "Harris"
                }
            ],
            "firstpage": "2818",
            "issn": "00085472",
            "lastpage": "2822",
            "pmid": "1970277",
            "pub_year": 1990,
            "title": "Reversal of Multidrug Resistance by Verapamil and Modulation by \u02511-Acid Glycoprotein in Wild-type and Multidrug-resistant Chinese Hamster Ovary Cell Lines",
            "volume": "50"
        },
        "bb0025": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Lehnert"
                },
                {
                    "first": "W. S.",
                    "initial": "W.S.",
                    "last": "Dalton"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Roe"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Emerson"
                },
                {
                    "first": "S. E.",
                    "initial": "S.E.",
                    "last": "Salmon"
                }
            ],
            "firstpage": "348",
            "issn": "00064971",
            "lastpage": "354",
            "pmid": "1670760",
            "pub_year": 1991,
            "title": "Synergistic inhibition by verapamil and quinine of P-glycoprotein-mediated multidrug resistance in a human myeloma cell line model",
            "volume": "77"
        },
        "bb0030": {
            "authors": [
                {
                    "first": "Alasdair J.G.",
                    "initial": "A.J.G.",
                    "last": "Gray"
                },
                {
                    "first": "Paul",
                    "initial": "P.",
                    "last": "Groth"
                },
                {
                    "first": "Antonis",
                    "initial": "A.",
                    "last": "Loizou"
                },
                {
                    "first": "Sune",
                    "initial": "S.",
                    "last": "Askjaer"
                },
                {
                    "first": "Christian",
                    "initial": "C.",
                    "last": "Brenninkmeijer"
                },
                {
                    "first": "Kees",
                    "initial": "K.",
                    "last": "Burger"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Chichester"
                },
                {
                    "first": "Chris T.",
                    "initial": "C.T.",
                    "last": "Evelo"
                },
                {
                    "first": "Carole",
                    "initial": "C.",
                    "last": "Goble"
                },
                {
                    "first": "Lee",
                    "initial": "L.",
                    "last": "Harland"
                },
                {
                    "first": "Steve",
                    "initial": "S.",
                    "last": "Pettifer"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Thompson"
                },
                {
                    "first": "Andra",
                    "initial": "A.",
                    "last": "Waagmeester"
                },
                {
                    "first": "Antony J.",
                    "initial": "A.J.",
                    "last": "Williams"
                }
            ],
            "doi": "10.3233/SW-2012-0088",
            "firstpage": "101",
            "issn": "15700844",
            "lastpage": "113",
            "pub_year": 2014,
            "title": "Applying linked data approaches to pharmacology: Architectural decisions and implementation",
            "volume": "5"
        },
        "bb0035": {
            "authors": [
                {
                    "first": "J. C.",
                    "initial": "J.C.",
                    "last": "Kalvass"
                },
                {
                    "first": "J. W.",
                    "initial": "J.W.",
                    "last": "Polli"
                },
                {
                    "first": "D. L.",
                    "initial": "D.L.",
                    "last": "Bourdet"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "Feng"
                },
                {
                    "first": "S. M.",
                    "initial": "S.M.",
                    "last": "Huang"
                },
                {
                    "first": "X.",
                    "initial": "X.",
                    "last": "Liu"
                },
                {
                    "first": "Q. R.",
                    "initial": "Q.R.",
                    "last": "Smith"
                },
                {
                    "first": "L. K.",
                    "initial": "L.K.",
                    "last": "Zhang"
                },
                {
                    "first": "M. J.",
                    "initial": "M.J.",
                    "last": "Zamek-Gliszczynski"
                }
            ],
            "doi": "10.1038/clpt.2013.34",
            "firstpage": "80",
            "issn": "00099236",
            "lastpage": "94",
            "pmid": "23588303",
            "pub_year": 2013,
            "title": "Why clinical modulation of efflux transport at the human blood-brain barrier is unlikely: The ITC evidence-based position",
            "volume": "94"
        },
        "bb0040": null,
        "bb0045": {
            "authors": [
                {
                    "first": "Chi Yuan",
                    "initial": "C.Y.",
                    "last": "Wu"
                },
                {
                    "first": "Leslie Z.",
                    "initial": "L.Z.",
                    "last": "Benet"
                }
            ],
            "doi": "10.1007/s11095-004-9004-4",
            "firstpage": "11",
            "issn": "07248741",
            "lastpage": "23",
            "pmid": "15771225",
            "pub_year": 2005,
            "title": "Predicting drug disposition via application of BCS: Transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system",
            "volume": "22"
        },
        "bb0050": {
            "authors": [
                {
                    "first": "Michel",
                    "initial": "M.",
                    "last": "Demeule"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "R\u00e9gina"
                },
                {
                    "first": "Julie",
                    "initial": "J.",
                    "last": "Jodoin"
                },
                {
                    "first": "Alain",
                    "initial": "A.",
                    "last": "Laplante"
                },
                {
                    "first": "Claude",
                    "initial": "C.",
                    "last": "Dagenais"
                },
                {
                    "first": "France",
                    "initial": "F.",
                    "last": "Berthelet"
                },
                {
                    "first": "Albert",
                    "initial": "A.",
                    "last": "Moghrabi"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "B\u00e9liveau"
                }
            ],
            "doi": "10.1016/S1537-1891(02)00201-X",
            "firstpage": "339",
            "issn": "15371891",
            "lastpage": "348",
            "pmid": "12529928",
            "pub_year": 2002,
            "title": "Drug transport to the brain: Key roles for the efflux pump P-glycoprotein in the blood-brain barrier",
            "volume": "38"
        },
        "bb0055": {
            "authors": [
                {
                    "first": "Valentino",
                    "initial": "V.",
                    "last": "Laquintana"
                },
                {
                    "first": "Adriana",
                    "initial": "A.",
                    "last": "Trapani"
                },
                {
                    "first": "Nunzio",
                    "initial": "N.",
                    "last": "Denora"
                },
                {
                    "first": "Fan",
                    "initial": "F.",
                    "last": "Wang"
                },
                {
                    "first": "James M.",
                    "initial": "J.M.",
                    "last": "Gallo"
                },
                {
                    "first": "Giuseppe",
                    "initial": "G.",
                    "last": "Trapani"
                }
            ],
            "doi": "10.1517/17425240903167942",
            "firstpage": "1017",
            "issn": "17425247",
            "lastpage": "1032",
            "pmid": "19732031",
            "pub_year": 2009,
            "title": "New strategies to deliver anticancer drugs to brain tumors",
            "volume": "6"
        },
        "bb0060": {
            "authors": [
                {
                    "first": "Selvi",
                    "initial": "S.",
                    "last": "Durmus"
                },
                {
                    "first": "Rolf W.",
                    "initial": "R.W.",
                    "last": "Sparidans"
                },
                {
                    "first": "Anita",
                    "initial": "A.",
                    "last": "Van Esch"
                },
                {
                    "first": "Els",
                    "initial": "E.",
                    "last": "Wagenaar"
                },
                {
                    "first": "Jos H.",
                    "initial": "J.H.",
                    "last": "Beijnen"
                },
                {
                    "first": "Alfred H.",
                    "initial": "A.H.",
                    "last": "Schinkel"
                }
            ],
            "doi": "10.1007/s11095-014-1442-z",
            "firstpage": "37",
            "issn": "07248741",
            "lastpage": "46",
            "pmid": "24962512",
            "pub_year": 2015,
            "title": "Breast cancer resistance protein (BCRP/ABCG2) and P-glycoprotein (P-GP/ABCB1) restrict oral availability and brain accumulation of the PARP inhibitor rucaparib (AG-014699)",
            "volume": "32"
        },
        "bb0065": {
            "authors": [
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Durmus"
                },
                {
                    "first": "N.",
                    "initial": "N.",
                    "last": "Xu"
                },
                {
                    "first": "R. W.",
                    "initial": "R.W.",
                    "last": "Sparidans"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Wagenaar"
                },
                {
                    "first": "J. H.",
                    "initial": "J.H.",
                    "last": "Beijnen"
                },
                {
                    "first": "A. H.",
                    "initial": "A.H.",
                    "last": "Schinkel"
                }
            ],
            "doi": "10.1016/j.phrs.2013.06.009",
            "firstpage": "9",
            "issn": "10436618",
            "lastpage": "16",
            "pmid": "23827160",
            "pub_year": 2013,
            "title": "P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387",
            "volume": "76"
        },
        "bb0070": {
            "authors": [
                {
                    "first": "Sharan K.",
                    "initial": "S.K.",
                    "last": "Bagal"
                },
                {
                    "first": "Peter J.",
                    "initial": "P.J.",
                    "last": "Bungay"
                }
            ],
            "doi": "10.1021/ml300378n",
            "firstpage": "948",
            "issn": "19485875",
            "lastpage": "950",
            "pub_year": 2012,
            "title": "Minimizing drug exposure in the CNS while maintaining good oral absorption",
            "volume": "3"
        },
        "bb0075": {
            "authors": [
                {
                    "first": "Lucy",
                    "initial": "L.",
                    "last": "Sanchez-Covarrubias"
                },
                {
                    "first": "Lauren M.",
                    "initial": "L.M.",
                    "last": "Slosky"
                },
                {
                    "first": "Brandon J.",
                    "initial": "B.J.",
                    "last": "Thompson"
                },
                {
                    "first": "Yifeng",
                    "initial": "Y.",
                    "last": "Zhang"
                },
                {
                    "first": "Mei Li",
                    "initial": "M.L.",
                    "last": "Laracuente"
                },
                {
                    "first": "Kristin M.",
                    "initial": "K.M.",
                    "last": "DeMarco"
                },
                {
                    "first": "Patrick T.",
                    "initial": "P.T.",
                    "last": "Ronaldson"
                },
                {
                    "first": "Thomas P.",
                    "initial": "T.P.",
                    "last": "Davis"
                }
            ],
            "doi": "10.1371/journal.pone.0088516",
            "issn": "19326203",
            "pmid": "24520393",
            "pub_year": 2014,
            "title": "P-glycoprotein modulates morphine uptake into the CNS: A role for the non-steroidal anti-inflammatory drug diclofenac",
            "volume": "9"
        },
        "bb0080": {
            "authors": [
                {
                    "first": "Frans J.C.",
                    "initial": "F.J.C.",
                    "last": "Cuperus"
                },
                {
                    "first": "Thierry",
                    "initial": "T.",
                    "last": "Claudel"
                },
                {
                    "first": "Julien",
                    "initial": "J.",
                    "last": "Gautherot"
                },
                {
                    "first": "Emina",
                    "initial": "E.",
                    "last": "Halilbasic"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Trauner"
                }
            ],
            "doi": "10.1124/dmd.113.056358",
            "firstpage": "546",
            "issn": "00909556",
            "lastpage": "560",
            "pmid": "24474736",
            "pub_year": 2014,
            "title": "The role of canalicular ABC transporters in cholestasis",
            "volume": "42"
        },
        "bb0085": {
            "authors": [
                {
                    "first": "Katrin",
                    "initial": "K.",
                    "last": "Wlcek"
                },
                {
                    "first": "Bruno",
                    "initial": "B.",
                    "last": "Stieger"
                }
            ],
            "doi": "10.1002/biof.1136",
            "firstpage": "188",
            "issn": "09516433",
            "lastpage": "198",
            "pmid": "24105869",
            "pub_year": 2014,
            "title": "ATP-binding cassette transporters in liver",
            "volume": "40"
        },
        "bb0090": {
            "authors": [
                {
                    "first": "Sarah",
                    "initial": "S.",
                    "last": "Dawson"
                },
                {
                    "first": "Simone",
                    "initial": "S.",
                    "last": "Stahl"
                },
                {
                    "first": "Nikki",
                    "initial": "N.",
                    "last": "Paul"
                },
                {
                    "first": "Jane",
                    "initial": "J.",
                    "last": "Barber"
                },
                {
                    "first": "J. Gerald",
                    "initial": "J.G.",
                    "last": "Kenna"
                }
            ],
            "doi": "10.1124/dmd.111.040758",
            "firstpage": "130",
            "issn": "00909556",
            "lastpage": "138",
            "pmid": "21965623",
            "pub_year": 2012,
            "title": "In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans",
            "volume": "40"
        },
        "bb0095": {
            "authors": [
                {
                    "first": "Edward J.",
                    "initial": "E.J.",
                    "last": "Andress"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Nicolaou"
                },
                {
                    "first": "Marta R.",
                    "initial": "M.R.",
                    "last": "Romero"
                },
                {
                    "first": "Sandhia",
                    "initial": "S.",
                    "last": "Naik"
                },
                {
                    "first": "Peter H.",
                    "initial": "P.H.",
                    "last": "Dixon"
                },
                {
                    "first": "Catherine",
                    "initial": "C.",
                    "last": "Williamson"
                },
                {
                    "first": "Kenneth J.",
                    "initial": "K.J.",
                    "last": "Linton"
                }
            ],
            "doi": "10.1002/hep.26970",
            "firstpage": "1921",
            "issn": "02709139",
            "lastpage": "1931",
            "pmid": "24806754",
            "pub_year": 2014,
            "title": "Molecular mechanistic explanation for the spectrum of cholestatic disease caused by the S320F variant of ABCB4",
            "volume": "59"
        },
        "bb0100": {
            "authors": [
                {
                    "first": "David C.",
                    "initial": "D.C.",
                    "last": "Gadsby"
                },
                {
                    "first": "Paola",
                    "initial": "P.",
                    "last": "Vergani"
                },
                {
                    "first": "L\u00e1szl\u00f3",
                    "initial": "L.",
                    "last": "Csan\u00e1dy"
                }
            ],
            "doi": "10.1038/nature04712",
            "firstpage": "477",
            "issn": "00280836",
            "lastpage": "483",
            "pmid": "16554808",
            "pub_year": 2006,
            "title": "The ABC protein turned chloride channel whose failure causes cystic fibrosis",
            "volume": "440"
        },
        "bb0105": {
            "authors": [
                {
                    "first": "Ikuo",
                    "initial": "I.",
                    "last": "Machida"
                },
                {
                    "first": "Shinya",
                    "initial": "S.",
                    "last": "Wakusawa"
                },
                {
                    "first": "Fujiko",
                    "initial": "F.",
                    "last": "Sanae"
                },
                {
                    "first": "Hisao",
                    "initial": "H.",
                    "last": "Hayashi"
                },
                {
                    "first": "Atsushi",
                    "initial": "A.",
                    "last": "Kusakabe"
                },
                {
                    "first": "Hiroshi",
                    "initial": "H.",
                    "last": "Ninomiya"
                },
                {
                    "first": "Motoyoshi",
                    "initial": "M.",
                    "last": "Yano"
                },
                {
                    "first": "Kentaro",
                    "initial": "K.",
                    "last": "Yoshioka"
                }
            ],
            "doi": "10.1007/s00535-004-1555-y",
            "firstpage": "366",
            "issn": "09441174",
            "lastpage": "370",
            "pmid": "15870973",
            "pub_year": 2005,
            "title": "Mutational analysis of the MRP2 gene and long-term follow-up of Dubin-Johnson syndrome in Japan.",
            "volume": "40"
        },
        "bb0110": {
            "authors": [
                {
                    "first": "Jamie",
                    "initial": "J.",
                    "last": "Cameron"
                },
                {
                    "first": "Trine",
                    "initial": "T.",
                    "last": "Ranheim"
                },
                {
                    "first": "Bente",
                    "initial": "B.",
                    "last": "Halvorsen"
                },
                {
                    "first": "Mari Ann",
                    "initial": "M.A.",
                    "last": "Kulseth"
                },
                {
                    "first": "Trond P.",
                    "initial": "T.P.",
                    "last": "Leren"
                },
                {
                    "first": "Knut Erik",
                    "initial": "K.E.",
                    "last": "Berge"
                }
            ],
            "doi": "10.1016/j.atherosclerosis.2009.08.039",
            "firstpage": "163",
            "issn": "00219150",
            "lastpage": "166",
            "pmid": "19765707",
            "pub_year": 2010,
            "title": "Tangier disease caused by compound heterozygosity for ABCA1 mutations R282X and Y1532C",
            "volume": "209"
        },
        "bb0115": {
            "authors": [
                {
                    "first": "Hirotaka",
                    "initial": "H.",
                    "last": "Matsuo"
                },
                {
                    "first": "Tappei",
                    "initial": "T.",
                    "last": "Takada"
                },
                {
                    "first": "Kimiyoshi",
                    "initial": "K.",
                    "last": "Ichida"
                },
                {
                    "first": "Takahiro",
                    "initial": "T.",
                    "last": "Nakamura"
                },
                {
                    "first": "Akiyoshi",
                    "initial": "A.",
                    "last": "Nakayama"
                },
                {
                    "first": "Hiroshi",
                    "initial": "H.",
                    "last": "Suzuki"
                },
                {
                    "first": "Tatsuo",
                    "initial": "T.",
                    "last": "Hosoya"
                },
                {
                    "first": "Nariyoshi",
                    "initial": "N.",
                    "last": "Shinomiya"
                }
            ],
            "doi": "10.1080/15257770.2011.633954",
            "firstpage": "1117",
            "issn": "15257770",
            "lastpage": "1128",
            "pmid": "22132966",
            "pub_year": 2011,
            "title": "ABCG2/BCRP dysfunction as a major cause of gout",
            "volume": "30"
        },
        "bb0120": {
            "authors": [
                {
                    "first": "Alaa H.",
                    "initial": "A.H.",
                    "last": "Abuznait"
                },
                {
                    "first": "Amal",
                    "initial": "A.",
                    "last": "Kaddoumi"
                }
            ],
            "doi": "10.1021/cn300077c",
            "firstpage": "820",
            "issn": "19487193",
            "lastpage": "831",
            "pmid": "23181169",
            "pub_year": 2012,
            "title": "Role of ABC transporters in the pathogenesis of Alzheimers disease",
            "volume": "3"
        },
        "bb0125": {
            "authors": [
                {
                    "first": "Bernd",
                    "initial": "B.",
                    "last": "Greiner"
                },
                {
                    "first": "Michel",
                    "initial": "M.",
                    "last": "Eichelbaum"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Fritz"
                },
                {
                    "first": "Hans Peter",
                    "initial": "H.P.",
                    "last": "Kreichgauer"
                },
                {
                    "first": "Oliver",
                    "initial": "O.",
                    "last": "Von Richter"
                },
                {
                    "first": "Johannes",
                    "initial": "J.",
                    "last": "Zundler"
                },
                {
                    "first": "Heyo K.",
                    "initial": "H.K.",
                    "last": "Kroemer"
                }
            ],
            "doi": "10.1172/JCI6663",
            "firstpage": "147",
            "issn": "00219738",
            "lastpage": "153",
            "pmid": "10411543",
            "pub_year": 1999,
            "title": "The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin",
            "volume": "104"
        },
        "bb0130": {
            "authors": [
                {
                    "first": "Edna F.",
                    "initial": "E.F.",
                    "last": "Choo"
                },
                {
                    "first": "Brenda",
                    "initial": "B.",
                    "last": "Leake"
                },
                {
                    "first": "Christoph",
                    "initial": "C.",
                    "last": "Wandel"
                },
                {
                    "first": "Hitoshi",
                    "initial": "H.",
                    "last": "Imamura"
                },
                {
                    "first": "Alastair J.J.",
                    "initial": "A.J.J.",
                    "last": "Wood"
                },
                {
                    "first": "Grant R.",
                    "initial": "G.R.",
                    "last": "Wilkinson"
                },
                {
                    "first": "Richard B.",
                    "initial": "R.B.",
                    "last": "Kim"
                }
            ],
            "firstpage": "655",
            "issn": "00909556",
            "lastpage": "660",
            "pmid": "10820137",
            "pub_year": 2000,
            "title": "Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes",
            "volume": "28"
        },
        "bb0135": {
            "authors": [
                {
                    "first": "Yukari",
                    "initial": "Y.",
                    "last": "Umeyama"
                },
                {
                    "first": "Yasushi",
                    "initial": "Y.",
                    "last": "Fujioka"
                },
                {
                    "first": "Teruaki",
                    "initial": "T.",
                    "last": "Okuda"
                }
            ],
            "doi": "10.3109/00498254.2014.928958",
            "firstpage": "1135",
            "issn": "00498254",
            "lastpage": "1144",
            "pmid": "24937160",
            "pub_year": 2014,
            "title": "Clarification of P-glycoprotein inhibition-related drug-drug interaction risks based on a literature search of the clinical information",
            "volume": "44"
        },
        "bb0140": {
            "authors": [
                {
                    "first": "Gwenaelle",
                    "initial": "G.",
                    "last": "Conseil"
                },
                {
                    "first": "Helene",
                    "initial": "H.",
                    "last": "Baubichon-Cortay"
                },
                {
                    "first": "Guila",
                    "initial": "G.",
                    "last": "Dayan"
                },
                {
                    "first": "Jean Michel",
                    "initial": "J.M.",
                    "last": "Jault"
                },
                {
                    "first": "Denis",
                    "initial": "D.",
                    "last": "Barron"
                },
                {
                    "first": "Attilio",
                    "initial": "A.",
                    "last": "Di Pietro"
                }
            ],
            "doi": "10.1073/pnas.95.17.9831",
            "firstpage": "9831",
            "issn": "00278424",
            "lastpage": "9836",
            "pmid": "9707561",
            "pub_year": 1998,
            "title": "Flavonoids: A class of modulators with bifunctional interactions at vicinal ATP-and steroid-binding sites on mouse P-glycoprotein",
            "volume": "95"
        },
        "bb0145": {
            "authors": [
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Comte"
                },
                {
                    "first": "J. B.",
                    "initial": "J.B.",
                    "last": "Daskiewicz"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Bayet"
                },
                {
                    "first": "G.",
                    "initial": "G.",
                    "last": "Conseil"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Viornery-Vanier"
                },
                {
                    "first": "C.",
                    "initial": "C.",
                    "last": "Dumontet"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Di Pietro"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Barron"
                }
            ],
            "doi": "10.1021/jm991128y",
            "firstpage": "763",
            "issn": "00222623",
            "lastpage": "768",
            "pub_year": 2001,
            "title": "C-isoprenylation of flavonoids enhances binding affinity toward P-glycoprotein and modulation of cancer cell chemoresistance",
            "volume": "44"
        },
        "bb0150": {
            "authors": [
                {
                    "first": "Olga",
                    "initial": "O.",
                    "last": "Weso\u0142owska"
                },
                {
                    "first": "Jerzy",
                    "initial": "J.",
                    "last": "Wi\u015bniewski"
                },
                {
                    "first": "Kamila",
                    "initial": "K.",
                    "last": "\u015aroda"
                },
                {
                    "first": "Agnieszka",
                    "initial": "A.",
                    "last": "Krawczenko"
                },
                {
                    "first": "Aleksandra",
                    "initial": "A.",
                    "last": "Bielawska-Pohl"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Paprocka"
                },
                {
                    "first": "Danuta",
                    "initial": "D.",
                    "last": "Du\u015b"
                },
                {
                    "first": "Krystyna",
                    "initial": "K.",
                    "last": "Michalak"
                }
            ],
            "doi": "10.1016/j.ejphar.2010.06.069",
            "firstpage": "32",
            "issn": "00142999",
            "lastpage": "40",
            "pmid": "20633549",
            "pub_year": 2010,
            "title": "8-Prenylnaringenin is an inhibitor of multidrug resistance-associated transporters, P-glycoprotein and MRP1",
            "volume": "644"
        },
        "bb0155": {
            "authors": [
                {
                    "first": "Kee W.",
                    "initial": "K.W.",
                    "last": "Tan"
                },
                {
                    "first": "Yan",
                    "initial": "Y.",
                    "last": "Li"
                },
                {
                    "first": "James W.",
                    "initial": "J.W.",
                    "last": "Paxton"
                },
                {
                    "first": "Nigel P.",
                    "initial": "N.P.",
                    "last": "Birch"
                },
                {
                    "first": "Arjan",
                    "initial": "A.",
                    "last": "Scheepens"
                }
            ],
            "doi": "10.1016/j.foodchem.2012.12.021",
            "firstpage": "2267",
            "issn": "03088146",
            "lastpage": "2274",
            "pmid": "23497885",
            "pub_year": 2013,
            "title": "Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP/ABCG2)",
            "volume": "138"
        },
        "bb0160": {
            "authors": [
                {
                    "first": "Bill J.",
                    "initial": "B.J.",
                    "last": "Gurley"
                },
                {
                    "first": "Ashley",
                    "initial": "A.",
                    "last": "Swain"
                },
                {
                    "first": "D. Keith",
                    "initial": "D.K.",
                    "last": "Williams"
                },
                {
                    "first": "Gary",
                    "initial": "G.",
                    "last": "Barone"
                },
                {
                    "first": "Sunil K.",
                    "initial": "S.K.",
                    "last": "Battu"
                }
            ],
            "doi": "10.1002/mnfr.200700081",
            "firstpage": "772",
            "issn": "16134125",
            "lastpage": "779",
            "pmid": "18214850",
            "pub_year": 2008,
            "title": "Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: Comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics",
            "volume": "52"
        },
        "bb0165": {
            "authors": [
                {
                    "first": "Cheng",
                    "initial": "C.",
                    "last": "Chang"
                },
                {
                    "first": "Peter W.",
                    "initial": "P.W.",
                    "last": "Swaan"
                }
            ],
            "doi": "10.1016/j.ejps.2005.09.013",
            "firstpage": "411",
            "issn": "09280987",
            "lastpage": "424",
            "pmid": "16274971",
            "pub_year": 2006,
            "title": "Computational approaches to modeling drug transporters",
            "volume": "27"
        },
        "bb0170": {
            "authors": [
                {
                    "first": "Lei",
                    "initial": "L.",
                    "last": "Chen"
                },
                {
                    "first": "Youyong",
                    "initial": "Y.",
                    "last": "Li"
                },
                {
                    "first": "Huidong",
                    "initial": "H.",
                    "last": "Yu"
                },
                {
                    "first": "Liling",
                    "initial": "L.",
                    "last": "Zhang"
                },
                {
                    "first": "Tingjun",
                    "initial": "T.",
                    "last": "Hou"
                }
            ],
            "doi": "10.1016/j.drudis.2011.11.003",
            "firstpage": "343",
            "issn": "13596446",
            "lastpage": "351",
            "pmid": "22119877",
            "pub_year": 2012,
            "title": "Computational models for predicting substrates or inhibitors of P-glycoprotein",
            "volume": "17"
        },
        "bb0175": {
            "authors": [
                {
                    "first": "Gerhard F.",
                    "initial": "G.F.",
                    "last": "Ecker"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Stockner"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Chiba"
                }
            ],
            "doi": "10.1016/j.drudis.2007.12.012",
            "firstpage": "311",
            "issn": "13596446",
            "lastpage": "317",
            "pmid": "18405843",
            "pub_year": 2008,
            "title": "Computational models for prediction of interactions with ABC-transporters",
            "volume": "13"
        },
        "bb0180": {
            "authors": [
                {
                    "first": "Cheng",
                    "initial": "C.",
                    "last": "Chang"
                },
                {
                    "first": "Sean",
                    "initial": "S.",
                    "last": "Ekins"
                },
                {
                    "first": "Praveen",
                    "initial": "P.",
                    "last": "Bahadduri"
                },
                {
                    "first": "Peter W.",
                    "initial": "P.W.",
                    "last": "Swaan"
                }
            ],
            "doi": "10.1016/j.addr.2006.09.006",
            "firstpage": "1431",
            "issn": "0169409X",
            "lastpage": "1450",
            "pmid": "17097188",
            "pub_year": 2006,
            "title": "Pharmacophore-based discovery of ligands for drug transporters",
            "volume": "58"
        },
        "bb0185": {
            "authors": [
                {
                    "first": "Michael A.",
                    "initial": "M.A.",
                    "last": "Demel"
                },
                {
                    "first": "O.",
                    "initial": "O.",
                    "last": "Kr\u00e4mer"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Ettmayer"
                },
                {
                    "first": "Eric E.J.",
                    "initial": "E.E.J.",
                    "last": "Haaksma"
                },
                {
                    "first": "Gerhard F.",
                    "initial": "G.F.",
                    "last": "Ecker"
                }
            ],
            "doi": "10.1002/cbdv.200900138",
            "firstpage": "1960",
            "issn": "16121872",
            "lastpage": "1969",
            "pmid": "19937827",
            "pub_year": 2009,
            "title": "Predicting ligand interactions with ABC transporters in ADME",
            "volume": "6"
        },
        "bb0190": {
            "authors": [
                {
                    "first": "Yash A.",
                    "initial": "Y.A.",
                    "last": "Gandhi"
                },
                {
                    "first": "Marilyn E.",
                    "initial": "M.E.",
                    "last": "Morris"
                }
            ],
            "doi": "10.1208/s12248-009-9132-1",
            "firstpage": "541",
            "issn": "15507416",
            "lastpage": "552",
            "pmid": "19629710",
            "pub_year": 2009,
            "title": "Structure-activity relationships and quantitative structure-activity relationships for breast cancer resistance protein (ABCG2)",
            "volume": "11"
        },
        "bb0195": {
            "authors": [
                {
                    "first": "Ishrat",
                    "initial": "I.",
                    "last": "Jabeen"
                },
                {
                    "first": "Karin",
                    "initial": "K.",
                    "last": "Pleban"
                },
                {
                    "first": "Uwe",
                    "initial": "U.",
                    "last": "Rinner"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Chiba"
                },
                {
                    "first": "Gerhard F.",
                    "initial": "G.F.",
                    "last": "Ecker"
                }
            ],
            "doi": "10.1021/jm201705f",
            "firstpage": "3261",
            "issn": "00222623",
            "lastpage": "3273",
            "pmid": "22452412",
            "pub_year": 2012,
            "title": "Structure-activity relationships, ligand efficiency, and lipophilic efficiency profiles of benzophenone-type inhibitors of the multidrug transporter P-glycoprotein",
            "volume": "55"
        },
        "bb0200": {
            "authors": [
                {
                    "first": "Fabio",
                    "initial": "F.",
                    "last": "Broccatelli"
                },
                {
                    "first": "Emanuele",
                    "initial": "E.",
                    "last": "Carosati"
                },
                {
                    "first": "Annalisa",
                    "initial": "A.",
                    "last": "Neri"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Frosini"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Goracci"
                },
                {
                    "first": "Tudor I.",
                    "initial": "T.I.",
                    "last": "Oprea"
                },
                {
                    "first": "Gabriele",
                    "initial": "G.",
                    "last": "Cruciani"
                }
            ],
            "doi": "10.1021/jm101421d",
            "firstpage": "1740",
            "issn": "00222623",
            "lastpage": "1751",
            "pmid": "21341745",
            "pub_year": 2011,
            "title": "A novel approach for predicting P-glycoprotein (ABCB1) inhibition using molecular interaction fields",
            "volume": "54"
        },
        "bb0205": {
            "authors": [
                {
                    "first": "Lei",
                    "initial": "L.",
                    "last": "Chen"
                },
                {
                    "first": "Youyong",
                    "initial": "Y.",
                    "last": "Li"
                },
                {
                    "first": "Qing",
                    "initial": "Q.",
                    "last": "Zhao"
                },
                {
                    "first": "Hui",
                    "initial": "H.",
                    "last": "Peng"
                },
                {
                    "first": "Tingjun",
                    "initial": "T.",
                    "last": "Hou"
                }
            ],
            "doi": "10.1021/mp100465q",
            "firstpage": "889",
            "issn": "15438384",
            "lastpage": "900",
            "pmid": "21413792",
            "pub_year": 2011,
            "title": "ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive partitioning and naive bayesian classification techniques",
            "volume": "8"
        },
        "bb0210": {
            "authors": [
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Chiba"
                },
                {
                    "first": "Danilo",
                    "initial": "D.",
                    "last": "Annibali"
                },
                {
                    "first": "Manuela",
                    "initial": "M.",
                    "last": "Hitzler"
                },
                {
                    "first": "Elisabeth",
                    "initial": "E.",
                    "last": "Richter"
                },
                {
                    "first": "Gerhard",
                    "initial": "G.",
                    "last": "Ecker"
                }
            ],
            "doi": "10.1016/S0014-827X(98)00035-4",
            "firstpage": "357",
            "issn": "0014827X",
            "lastpage": "364",
            "pub_year": 1998,
            "title": "Studies on propafenone-type modulators of multidrug resistance VI. Synthesis and pharmacological activity of compounds with varied spacer length between the central aromatic ring and the nitrogen atom",
            "volume": "53"
        },
        "bb0215": {
            "authors": [
                {
                    "first": "Floriane",
                    "initial": "F.",
                    "last": "Montanari"
                },
                {
                    "first": "Gerhard F.",
                    "initial": "G.F.",
                    "last": "Ecker"
                }
            ],
            "doi": "10.1002/minf.201400012",
            "firstpage": "322",
            "issn": "18681743",
            "lastpage": "331",
            "pub_year": 2014,
            "title": "BCRP inhibition: From data collection to Ligand-based modeling",
            "volume": "33"
        },
        "bb0220": {
            "authors": [
                {
                    "first": "Daniel J.",
                    "initial": "D.J.",
                    "last": "Warner"
                },
                {
                    "first": "Hongming",
                    "initial": "H.",
                    "last": "Chen"
                },
                {
                    "first": "Louis David",
                    "initial": "L.D.",
                    "last": "Cantin"
                },
                {
                    "first": "J. Gerry",
                    "initial": "J.G.",
                    "last": "Kenna"
                },
                {
                    "first": "Simone",
                    "initial": "S.",
                    "last": "Stahl"
                },
                {
                    "first": "Clare L.",
                    "initial": "C.L.",
                    "last": "Walker"
                },
                {
                    "first": "Tobias",
                    "initial": "T.",
                    "last": "Noeske"
                }
            ],
            "doi": "10.1124/dmd.112.047068",
            "firstpage": "2332",
            "issn": "00909556",
            "lastpage": "2341",
            "pmid": "22961681",
            "pub_year": 2012,
            "title": "Mitigating the inhibition of human bile salt export pump by drugs: Opportunities provided by physicochemical property modulation, in silico modeling, and structural modification",
            "volume": "40"
        },
        "bb0225": {
            "authors": [
                {
                    "first": "Jenny M.",
                    "initial": "J.M.",
                    "last": "Pedersen"
                },
                {
                    "first": "P\u00e4r",
                    "initial": "P.",
                    "last": "Matsson"
                },
                {
                    "first": "Christel A.S.",
                    "initial": "C.A.S.",
                    "last": "Bergstr\u00f6m"
                },
                {
                    "first": "Ulf",
                    "initial": "U.",
                    "last": "Norinder"
                },
                {
                    "first": "Janet",
                    "initial": "J.",
                    "last": "Hoogstraate"
                },
                {
                    "first": "Per",
                    "initial": "P.",
                    "last": "Artursson"
                }
            ],
            "doi": "10.1021/jm7015683",
            "firstpage": "3275",
            "issn": "00222623",
            "lastpage": "3287",
            "pmid": "18457386",
            "pub_year": 2008,
            "title": "Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2)",
            "volume": "51"
        },
        "bb0230": {
            "authors": [
                {
                    "first": "Andreia",
                    "initial": "A.",
                    "last": "Palmeira"
                },
                {
                    "first": "Freddy",
                    "initial": "F.",
                    "last": "Rodrigues"
                },
                {
                    "first": "Em\u00edlia",
                    "initial": "E.",
                    "last": "Sousa"
                },
                {
                    "first": "Madalena",
                    "initial": "M.",
                    "last": "Pinto"
                },
                {
                    "first": "M. Helena",
                    "initial": "M.H.",
                    "last": "Vasconcelos"
                },
                {
                    "first": "Miguel X.",
                    "initial": "M.X.",
                    "last": "Fernandes"
                }
            ],
            "doi": "10.1111/j.1747-0285.2011.01089.x",
            "firstpage": "57",
            "issn": "17470277",
            "lastpage": "72",
            "pmid": "21235729",
            "pub_year": 2011,
            "title": "New uses for old drugs: Pharmacophore-based screening for the discovery of P-glycoprotein inhibitors",
            "volume": "78"
        },
        "bb0235": {
            "authors": [
                {
                    "first": "Yongmei",
                    "initial": "Y.",
                    "last": "Pan"
                },
                {
                    "first": "Paresh P.",
                    "initial": "P.P.",
                    "last": "Chothe"
                },
                {
                    "first": "Peter W.",
                    "initial": "P.W.",
                    "last": "Swaan"
                }
            ],
            "doi": "10.1021/mp300547h",
            "firstpage": "1236",
            "issn": "15438384",
            "lastpage": "1248",
            "pmid": "23418667",
            "pub_year": 2013,
            "title": "Identification of novel breast cancer resistance protein (BCRP) inhibitors by virtual screening",
            "volume": "10"
        },
        "bb0240": {
            "authors": [
                {
                    "first": "Tina",
                    "initial": "T.",
                    "last": "Ritschel"
                },
                {
                    "first": "Susanne M.A.",
                    "initial": "S.M.A.",
                    "last": "Hermans"
                },
                {
                    "first": "Marieke",
                    "initial": "M.",
                    "last": "Schreurs"
                },
                {
                    "first": "Jeroen J.M.W.",
                    "initial": "J.J.M.W.",
                    "last": "Van Den Heuvel"
                },
                {
                    "first": "Jan B.",
                    "initial": "J.B.",
                    "last": "Koenderink"
                },
                {
                    "first": "Rick",
                    "initial": "R.",
                    "last": "Greupink"
                },
                {
                    "first": "Frans G.M.",
                    "initial": "F.G.M.",
                    "last": "Russel"
                }
            ],
            "doi": "10.1021/tx5000393",
            "firstpage": "873",
            "issn": "0893228X",
            "lastpage": "881",
            "pmid": "24713091",
            "pub_year": 2014,
            "title": "In silico identification and in vitro validation of potential cholestatic compounds through 3D ligand-based pharmacophore modeling of BSEP inhibitors",
            "volume": "27"
        },
        "bb0245": {
            "authors": [
                {
                    "first": "Hui",
                    "initial": "H.",
                    "last": "Zhang"
                },
                {
                    "first": "Ming Li",
                    "initial": "M.L.",
                    "last": "Xiang"
                },
                {
                    "first": "Ying Lan",
                    "initial": "Y.L.",
                    "last": "Zhao"
                },
                {
                    "first": "Yu Quan",
                    "initial": "Y.Q.",
                    "last": "Wei"
                },
                {
                    "first": "Sheng Yong",
                    "initial": "S.Y.",
                    "last": "Yang"
                }
            ],
            "doi": "10.1016/j.ejps.2008.11.014",
            "firstpage": "451",
            "issn": "09280987",
            "lastpage": "457",
            "pmid": "19124075",
            "pub_year": 2009,
            "title": "Support vector machine and pharmacophore-based prediction models of multidrug-resistance protein 2 (MRP2) inhibitors",
            "volume": "36"
        },
        "bb0250": {
            "authors": [
                {
                    "first": "Dan",
                    "initial": "D.",
                    "last": "Li"
                },
                {
                    "first": "Lei",
                    "initial": "L.",
                    "last": "Chen"
                },
                {
                    "first": "Youyong",
                    "initial": "Y.",
                    "last": "Li"
                },
                {
                    "first": "Sheng",
                    "initial": "S.",
                    "last": "Tian"
                },
                {
                    "first": "Huiyong",
                    "initial": "H.",
                    "last": "Sun"
                },
                {
                    "first": "Tingjun",
                    "initial": "T.",
                    "last": "Hou"
                }
            ],
            "doi": "10.1021/mp400450m",
            "firstpage": "716",
            "issn": "15438384",
            "lastpage": "726",
            "pmid": "24499501",
            "pub_year": 2014,
            "title": "ADMET evaluation in drug discovery. 13. Development of in silico prediction models for p-glycoprotein substrates",
            "volume": "11"
        },
        "bb0255": {
            "authors": [
                {
                    "first": "Zhi",
                    "initial": "Z.",
                    "last": "Wang"
                },
                {
                    "first": "Yuanying",
                    "initial": "Y.",
                    "last": "Chen"
                },
                {
                    "first": "Hu",
                    "initial": "H.",
                    "last": "Liang"
                },
                {
                    "first": "Andreas",
                    "initial": "A.",
                    "last": "Bender"
                },
                {
                    "first": "Robert C.",
                    "initial": "R.C.",
                    "last": "Glen"
                },
                {
                    "first": "Aixia",
                    "initial": "A.",
                    "last": "Yan"
                }
            ],
            "doi": "10.1021/ci2001583",
            "firstpage": "1447",
            "issn": "15499596",
            "lastpage": "1456",
            "pmid": "21604677",
            "pub_year": 2011,
            "title": "P-glycoprotein substrate models using support vector machines based on a comprehensive data set",
            "volume": "51"
        },
        "bb0260": {
            "authors": [
                {
                    "first": "Eszter",
                    "initial": "E.",
                    "last": "Hazai"
                },
                {
                    "first": "Istvan",
                    "initial": "I.",
                    "last": "Hazai"
                },
                {
                    "first": "Isabelle",
                    "initial": "I.",
                    "last": "Ragueneau-Majlessi"
                },
                {
                    "first": "Sophie P.",
                    "initial": "S.P.",
                    "last": "Chung"
                },
                {
                    "first": "Zsolt",
                    "initial": "Z.",
                    "last": "Bikadi"
                },
                {
                    "first": "Qingcheng",
                    "initial": "Q.",
                    "last": "Mao"
                }
            ],
            "doi": "10.1186/1471-2105-14-130",
            "issn": "14712105",
            "pmid": "23586520",
            "pub_year": 2013,
            "title": "Predicting substrates of the human breast cancer resistance protein using a support vector machine method",
            "volume": "14"
        },
        "bb0265": {
            "authors": [
                {
                    "first": "Marta",
                    "initial": "M.",
                    "last": "Pinto"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Trauner"
                },
                {
                    "first": "Gerhard F.",
                    "initial": "G.F.",
                    "last": "Ecker"
                }
            ],
            "doi": "10.1002/minf.201200049",
            "firstpage": "547",
            "issn": "18681743",
            "lastpage": "553",
            "pub_year": 2012,
            "title": "An in silico classification model for putative ABCC2 substrates",
            "volume": "31"
        },
        "bb0270": {
            "authors": [
                {
                    "first": "Gergely",
                    "initial": "G.",
                    "last": "Szak\u00e1cs"
                },
                {
                    "first": "Jean Philippe",
                    "initial": "J.P.",
                    "last": "Annereau"
                },
                {
                    "first": "Samir",
                    "initial": "S.",
                    "last": "Lababidi"
                },
                {
                    "first": "Uma",
                    "initial": "U.",
                    "last": "Shankavaram"
                },
                {
                    "first": "Angela",
                    "initial": "A.",
                    "last": "Arciello"
                },
                {
                    "first": "Kimberly J.",
                    "initial": "K.J.",
                    "last": "Bussey"
                },
                {
                    "first": "William",
                    "initial": "W.",
                    "last": "Reinhold"
                },
                {
                    "first": "Yanping",
                    "initial": "Y.",
                    "last": "Guo"
                },
                {
                    "first": "Gary D.",
                    "initial": "G.D.",
                    "last": "Kruh"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Reimers"
                },
                {
                    "first": "John N.",
                    "initial": "J.N.",
                    "last": "Weinstein"
                },
                {
                    "first": "Michael M.",
                    "initial": "M.M.",
                    "last": "Gottesman"
                }
            ],
            "doi": "10.1016/j.ccr.2004.06.026",
            "firstpage": "129",
            "issn": "15356108",
            "lastpage": "137",
            "pmid": "15324696",
            "pub_year": 2004,
            "title": "Predicting drug sensitivity and resistance: Profiling ABC transporter genes in cancer cells",
            "volume": "6"
        },
        "bb0275": {
            "authors": [
                {
                    "first": "P\u00e4r",
                    "initial": "P.",
                    "last": "Matsson"
                },
                {
                    "first": "Jenny M.",
                    "initial": "J.M.",
                    "last": "Pedersen"
                },
                {
                    "first": "Ulf",
                    "initial": "U.",
                    "last": "Norinder"
                },
                {
                    "first": "Christel A.S.",
                    "initial": "C.A.S.",
                    "last": "Bergstr\u00f6m"
                },
                {
                    "first": "Per",
                    "initial": "P.",
                    "last": "Artursson"
                }
            ],
            "doi": "10.1007/s11095-009-9896-0",
            "firstpage": "1816",
            "issn": "07248741",
            "lastpage": "1831",
            "pmid": "19421845",
            "pub_year": 2009,
            "title": "Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs",
            "volume": "26"
        },
        "bb0280": {
            "authors": [
                {
                    "first": "A. Patr\u00edcia",
                    "initial": "A.P.",
                    "last": "Bento"
                },
                {
                    "first": "Anna",
                    "initial": "A.",
                    "last": "Gaulton"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Hersey"
                },
                {
                    "first": "Louisa J.",
                    "initial": "L.J.",
                    "last": "Bellis"
                },
                {
                    "first": "Jon",
                    "initial": "J.",
                    "last": "Chambers"
                },
                {
                    "first": "Mark",
                    "initial": "M.",
                    "last": "Davies"
                },
                {
                    "first": "Felix A.",
                    "initial": "F.A.",
                    "last": "Kr\u00fcger"
                },
                {
                    "first": "Yvonne",
                    "initial": "Y.",
                    "last": "Light"
                },
                {
                    "first": "Lora",
                    "initial": "L.",
                    "last": "Mak"
                },
                {
                    "first": "Shaun",
                    "initial": "S.",
                    "last": "McGlinchey"
                },
                {
                    "first": "Michal",
                    "initial": "M.",
                    "last": "Nowotka"
                },
                {
                    "first": "George",
                    "initial": "G.",
                    "last": "Papadatos"
                },
                {
                    "first": "Rita",
                    "initial": "R.",
                    "last": "Santos"
                },
                {
                    "first": "John P.",
                    "initial": "J.P.",
                    "last": "Overington"
                }
            ],
            "doi": "10.1093/nar/gkt1031",
            "firstpage": "D1083",
            "issn": "03051048",
            "lastpage": "D1090",
            "pmid": "24214965",
            "pub_year": 2014,
            "title": "The ChEMBL bioactivity database: An update",
            "volume": "42"
        },
        "bb0285": {
            "authors": [
                {
                    "first": "Yanli",
                    "initial": "Y.",
                    "last": "Wang"
                },
                {
                    "first": "Jewen",
                    "initial": "J.",
                    "last": "Xiao"
                },
                {
                    "first": "Tugba O.",
                    "initial": "T.O.",
                    "last": "Suzek"
                },
                {
                    "first": "Jian",
                    "initial": "J.",
                    "last": "Zhang"
                },
                {
                    "first": "Jiyao",
                    "initial": "J.",
                    "last": "Wang"
                },
                {
                    "first": "Zhigang",
                    "initial": "Z.",
                    "last": "Zhou"
                },
                {
                    "first": "Lianyi",
                    "initial": "L.",
                    "last": "Han"
                },
                {
                    "first": "Karen",
                    "initial": "K.",
                    "last": "Karapetyan"
                },
                {
                    "first": "Svetlana",
                    "initial": "S.",
                    "last": "Dracheva"
                },
                {
                    "first": "Benjamin A.",
                    "initial": "B.A.",
                    "last": "Shoemaker"
                },
                {
                    "first": "Evan",
                    "initial": "E.",
                    "last": "Bolton"
                },
                {
                    "first": "Asta",
                    "initial": "A.",
                    "last": "Gindulyte"
                },
                {
                    "first": "Stephen H.",
                    "initial": "S.H.",
                    "last": "Bryant"
                }
            ],
            "doi": "10.1093/nar/gkr1132",
            "firstpage": "D400",
            "issn": "03051048",
            "lastpage": "D412",
            "pmid": "22140110",
            "pub_year": 2012,
            "title": "PubChem's BioAssay database",
            "volume": "40"
        },
        "bb0290": {
            "authors": [
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Zdrazil"
                },
                {
                    "first": "Marta",
                    "initial": "M.",
                    "last": "Pinto"
                },
                {
                    "first": "Poongavanam",
                    "initial": "P.",
                    "last": "Vasanthanathan"
                },
                {
                    "first": "Antony J.",
                    "initial": "A.J.",
                    "last": "Williams"
                },
                {
                    "first": "Linda Zander",
                    "initial": "L.Z.",
                    "last": "Balderud"
                },
                {
                    "first": "Ola",
                    "initial": "O.",
                    "last": "Engkvist"
                },
                {
                    "first": "Christine",
                    "initial": "C.",
                    "last": "Chichester"
                },
                {
                    "first": "Anne",
                    "initial": "A.",
                    "last": "Hersey"
                },
                {
                    "first": "John P.",
                    "initial": "J.P.",
                    "last": "Overington"
                },
                {
                    "first": "Gerhard F.",
                    "initial": "G.F.",
                    "last": "Ecker"
                }
            ],
            "doi": "10.1002/minf.201200059",
            "firstpage": "599",
            "issn": "18681743",
            "lastpage": "609",
            "pub_year": 2012,
            "title": "Annotating human P-glycoprotein bioassay data",
            "volume": "31"
        },
        "bb0295": {
            "authors": [
                {
                    "first": "Joe",
                    "initial": "J.",
                    "last": "Bentz"
                },
                {
                    "first": "Michael P.",
                    "initial": "M.P.",
                    "last": "O'Connor"
                },
                {
                    "first": "Dallas",
                    "initial": "D.",
                    "last": "Bednarczyk"
                },
                {
                    "first": "Joann",
                    "initial": "J.",
                    "last": "Coleman"
                },
                {
                    "first": "Caroline",
                    "initial": "C.",
                    "last": "Lee"
                },
                {
                    "first": "Johan",
                    "initial": "J.",
                    "last": "Palm"
                },
                {
                    "first": "Y. Anne",
                    "initial": "Y.A.",
                    "last": "Pak"
                },
                {
                    "first": "Elke S.",
                    "initial": "E.S.",
                    "last": "Perloff"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Reyner"
                },
                {
                    "first": "Praveen",
                    "initial": "P.",
                    "last": "Balimane"
                },
                {
                    "first": "Marie",
                    "initial": "M.",
                    "last": "Br\u00e4nnstr\u00f6m"
                },
                {
                    "first": "Xiaoyan",
                    "initial": "X.",
                    "last": "Chu"
                },
                {
                    "first": "Christoph",
                    "initial": "C.",
                    "last": "Funk"
                },
                {
                    "first": "Ailan",
                    "initial": "A.",
                    "last": "Guo"
                },
                {
                    "first": "Imad",
                    "initial": "I.",
                    "last": "Hanna"
                },
                {
                    "first": "Krisztina",
                    "initial": "K.",
                    "last": "Her\u00e9di-Szab\u00f3"
                },
                {
                    "first": "Kate",
                    "initial": "K.",
                    "last": "Hillgren"
                },
                {
                    "first": "Libin",
                    "initial": "L.",
                    "last": "Li"
                },
                {
                    "first": "Evelyn",
                    "initial": "E.",
                    "last": "Hollnack-Pusch"
                },
                {
                    "first": "Masoud",
                    "initial": "M.",
                    "last": "Jamei"
                },
                {
                    "first": "Xuena",
                    "initial": "X.",
                    "last": "Lin"
                },
                {
                    "first": "Andrew K.",
                    "initial": "A.K.",
                    "last": "Mason"
                },
                {
                    "first": "Sibylle",
                    "initial": "S.",
                    "last": "Neuhoff"
                },
                {
                    "first": "Aarti",
                    "initial": "A.",
                    "last": "Patel"
                },
                {
                    "first": "Lalitha",
                    "initial": "L.",
                    "last": "Podila"
                },
                {
                    "first": "Emile",
                    "initial": "E.",
                    "last": "Plise"
                },
                {
                    "first": "Ganesh",
                    "initial": "G.",
                    "last": "Rajaraman"
                },
                {
                    "first": "Laurent",
                    "initial": "L.",
                    "last": "Salphati"
                },
                {
                    "first": "Eric",
                    "initial": "E.",
                    "last": "Sands"
                },
                {
                    "first": "Mitchell E.",
                    "initial": "M.E.",
                    "last": "Taub"
                },
                {
                    "first": "Jan Shiang",
                    "initial": "J.S.",
                    "last": "Taur"
                },
                {
                    "first": "Dietmar",
                    "initial": "D.",
                    "last": "Weitz"
                },
                {
                    "first": "Heleen M.",
                    "initial": "H.M.",
                    "last": "Wortelboer"
                },
                {
                    "first": "Cindy Q.",
                    "initial": "C.Q.",
                    "last": "Xia"
                },
                {
                    "first": "Guangqing",
                    "initial": "G.",
                    "last": "Xiao"
                },
                {
                    "first": "Jocelyn",
                    "initial": "J.",
                    "last": "Yabut"
                },
                {
                    "first": "Tetsuo",
                    "initial": "T.",
                    "last": "Yamagata"
                },
                {
                    "first": "Lei",
                    "initial": "L.",
                    "last": "Zhang"
                },
                {
                    "first": "Harma",
                    "initial": "H.",
                    "last": "Ellens"
                }
            ],
            "doi": "10.1124/dmd.112.050500",
            "firstpage": "1347",
            "issn": "00909556",
            "lastpage": "1366",
            "pmid": "23620485",
            "pub_year": 2013,
            "title": "Variability in P-Glycoprotein Inhibitory Potency (IC50) Using Various in Vitro Experimental Systems: Implications for Universal Digoxin Drug- Drug Interaction Risk Assessment Decision Criterias",
            "volume": "41"
        },
        "bb0300": {
            "authors": [
                {
                    "first": "Praveen V.",
                    "initial": "P.V.",
                    "last": "Balimane"
                },
                {
                    "first": "Anthony",
                    "initial": "A.",
                    "last": "Marino"
                },
                {
                    "first": "Saeho",
                    "initial": "S.",
                    "last": "Chong"
                }
            ],
            "doi": "10.1208/s12248-008-9068-x",
            "firstpage": "577",
            "issn": "15507416",
            "lastpage": "586",
            "pmid": "19082742",
            "pub_year": 2008,
            "title": "P-gp inhibition potential in cell-based models: Which \"calculation\" method is the most accurate?",
            "volume": "10"
        },
        "bb0305": {
            "authors": [
                {
                    "first": "Nagdeep",
                    "initial": "N.",
                    "last": "Giri"
                },
                {
                    "first": "Sagar",
                    "initial": "S.",
                    "last": "Agarwal"
                },
                {
                    "first": "Naveed",
                    "initial": "N.",
                    "last": "Shaik"
                },
                {
                    "first": "Guoyu",
                    "initial": "G.",
                    "last": "Pan"
                },
                {
                    "first": "Ying",
                    "initial": "Y.",
                    "last": "Chen"
                },
                {
                    "first": "William F.",
                    "initial": "W.F.",
                    "last": "Elmquist"
                }
            ],
            "doi": "10.1124/dmd.108.022046",
            "firstpage": "560",
            "issn": "00909556",
            "lastpage": "570",
            "pmid": "19056916",
            "pub_year": 2009,
            "title": "Substrate-dependent breast cancer resistance protein (Bcrp1/Abcg2)-mediated interactions: Consideration of multiple binding sites in in vitro assay design",
            "volume": "37"
        },
        "bb0310": {
            "authors": [
                {
                    "first": "Chitra A.",
                    "initial": "C.A.",
                    "last": "Shintre"
                },
                {
                    "first": "Ashley C.W.",
                    "initial": "A.C.W.",
                    "last": "Pike"
                },
                {
                    "first": "Qiuhong",
                    "initial": "Q.",
                    "last": "Li"
                },
                {
                    "first": "Jung In",
                    "initial": "J.I.",
                    "last": "Kim"
                },
                {
                    "first": "Alastair J.",
                    "initial": "A.J.",
                    "last": "Barr"
                },
                {
                    "first": "Solenne",
                    "initial": "S.",
                    "last": "Goubin"
                },
                {
                    "first": "Leela",
                    "initial": "L.",
                    "last": "Shrestha"
                },
                {
                    "first": "Jing",
                    "initial": "J.",
                    "last": "Yang"
                },
                {
                    "first": "Georgina",
                    "initial": "G.",
                    "last": "Berridge"
                },
                {
                    "first": "Jonathan",
                    "initial": "J.",
                    "last": "Ross"
                },
                {
                    "first": "Phillip J.",
                    "initial": "P.J.",
                    "last": "Stansfeld"
                },
                {
                    "first": "Mark S.P.",
                    "initial": "M.S.P.",
                    "last": "Sansom"
                },
                {
                    "first": "Aled M.",
                    "initial": "A.M.",
                    "last": "Edward"
                },
                {
                    "first": "Chas",
                    "initial": "C.",
                    "last": "Bountra"
                },
                {
                    "first": "Brian D.",
                    "initial": "B.D.",
                    "last": "Marsden"
                },
                {
                    "first": "Frank",
                    "initial": "F.",
                    "last": "Von Delft"
                },
                {
                    "first": "Alex N.",
                    "initial": "A.N.",
                    "last": "Bullock"
                },
                {
                    "first": "Opher",
                    "initial": "O.",
                    "last": "Gileadi"
                },
                {
                    "first": "Nicola A.",
                    "initial": "N.A.",
                    "last": "Burgess-Brown"
                },
                {
                    "first": "Elisabeth P.",
                    "initial": "E.P.",
                    "last": "Carpenter"
                }
            ],
            "doi": "10.1073/pnas.1217042110",
            "firstpage": "9710",
            "issn": "00278424",
            "lastpage": "9715",
            "pmid": "23716676",
            "pub_year": 2013,
            "title": "Structures of ABCB10, a human ATP-binding cassette transporter in apo- And nucleotide-bound states",
            "volume": "110"
        },
        "bb0315": {
            "authors": [
                {
                    "first": "Frances C.",
                    "initial": "F.C.",
                    "last": "Bernstein"
                },
                {
                    "first": "Thomas F.",
                    "initial": "T.F.",
                    "last": "Koetzle"
                },
                {
                    "first": "Graheme J.B.",
                    "initial": "G.J.B.",
                    "last": "Williams"
                },
                {
                    "first": "Edgar F.",
                    "initial": "E.F.",
                    "last": "Meyer"
                },
                {
                    "first": "Michael D.",
                    "initial": "M.D.",
                    "last": "Brice"
                },
                {
                    "first": "John R.",
                    "initial": "J.R.",
                    "last": "Rodgers"
                },
                {
                    "first": "Olga",
                    "initial": "O.",
                    "last": "Kennard"
                },
                {
                    "first": "Takehiko",
                    "initial": "T.",
                    "last": "Shimanouchi"
                },
                {
                    "first": "Mitsuo",
                    "initial": "M.",
                    "last": "Tasumi"
                }
            ],
            "doi": "10.1016/S0022-2836(77)80200-3",
            "firstpage": "535",
            "issn": "00222836",
            "lastpage": "542",
            "pmid": "875032",
            "pub_year": 1977,
            "title": "The protein data bank: A computer-based archival file for macromolecular structures",
            "volume": "112"
        },
        "bb0325": {
            "authors": [
                {
                    "first": "Stephen G.",
                    "initial": "S.G.",
                    "last": "Aller"
                },
                {
                    "first": "Jodie",
                    "initial": "J.",
                    "last": "Yu"
                },
                {
                    "first": "Andrew",
                    "initial": "A.",
                    "last": "Ward"
                },
                {
                    "first": "Yue",
                    "initial": "Y.",
                    "last": "Weng"
                },
                {
                    "first": "Srinivas",
                    "initial": "S.",
                    "last": "Chittaboina"
                },
                {
                    "first": "Rupeng",
                    "initial": "R.",
                    "last": "Zhuo"
                },
                {
                    "first": "Patina M.",
                    "initial": "P.M.",
                    "last": "Harrell"
                },
                {
                    "first": "Yenphuong T.",
                    "initial": "Y.T.",
                    "last": "Trinh"
                },
                {
                    "first": "Qinghai",
                    "initial": "Q.",
                    "last": "Zhang"
                },
                {
                    "first": "Ina L.",
                    "initial": "I.L.",
                    "last": "Urbatsch"
                },
                {
                    "first": "Geoffrey",
                    "initial": "G.",
                    "last": "Chang"
                }
            ],
            "doi": "10.1126/science.1168750",
            "firstpage": "1718",
            "issn": "00368075",
            "lastpage": "1722",
            "pmid": "19325113",
            "pub_year": 2009,
            "title": "Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding",
            "volume": "323"
        },
        "bb0365": {
            "authors": [
                {
                    "first": "Christopher A.",
                    "initial": "C.A.",
                    "last": "McDevitt"
                },
                {
                    "first": "Richard",
                    "initial": "R.",
                    "last": "Callaghan"
                }
            ],
            "doi": "10.1016/j.pharmthera.2006.10.003",
            "firstpage": "429",
            "issn": "01637258",
            "lastpage": "441",
            "pmid": "17208306",
            "pub_year": 2007,
            "title": "How can we best use structural information on P-glycoprotein to design inhibitors?",
            "volume": "113"
        },
        "bb0370": {
            "authors": [
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Dolghih"
                },
                {
                    "first": "Clifford",
                    "initial": "C.",
                    "last": "Bryant"
                },
                {
                    "first": "Adam R.",
                    "initial": "A.R.",
                    "last": "Renslo"
                },
                {
                    "first": "Matthew P.",
                    "initial": "M.P.",
                    "last": "Jacobson"
                }
            ],
            "doi": "10.1371/journal.pcbi.1002083",
            "issn": "1553734X",
            "pmid": "21731480",
            "pub_year": 2011,
            "title": "Predicting binding to P-glycoprotein by flexible receptor docking",
            "volume": "7"
        },
        "bb0375": {
            "authors": [
                {
                    "first": "Kelly M.",
                    "initial": "K.M.",
                    "last": "Mahar Doan"
                },
                {
                    "first": "Joan E.",
                    "initial": "J.E.",
                    "last": "Humphreys"
                },
                {
                    "first": "Lindsey O.",
                    "initial": "L.O.",
                    "last": "Webster"
                },
                {
                    "first": "Stephen A.",
                    "initial": "S.A.",
                    "last": "Wring"
                },
                {
                    "first": "Larry J.",
                    "initial": "L.J.",
                    "last": "Shampine"
                },
                {
                    "first": "Cosette J.",
                    "initial": "C.J.",
                    "last": "Serabjit-Singh"
                },
                {
                    "first": "Kimberly K.",
                    "initial": "K.K.",
                    "last": "Adkison"
                },
                {
                    "first": "Joseph W.",
                    "initial": "J.W.",
                    "last": "Polli"
                }
            ],
            "doi": "10.1124/jpet.102.039255",
            "firstpage": "1029",
            "issn": "00223565",
            "lastpage": "1037",
            "pmid": "12438524",
            "pub_year": 2002,
            "title": "Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs",
            "volume": "303"
        },
        "bb0380": {
            "authors": [
                {
                    "first": "Freya",
                    "initial": "F.",
                    "last": "Klepsch"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Chiba"
                },
                {
                    "first": "Gerhard F.",
                    "initial": "G.F.",
                    "last": "Ecker"
                }
            ],
            "doi": "10.1371/journal.pcbi.1002036",
            "issn": "1553734X",
            "pmid": "21589945",
            "pub_year": 2011,
            "title": "Exhaustive sampling of docking poses reveals binding hypotheses for propafenone type inhibitors of p-glycoprotein",
            "volume": "7"
        },
        "bb0385": {
            "authors": [
                {
                    "first": "Freya",
                    "initial": "F.",
                    "last": "Klepsch"
                },
                {
                    "first": "Poongavanam",
                    "initial": "P.",
                    "last": "Vasanthanathan"
                },
                {
                    "first": "Gerhard F.",
                    "initial": "G.F.",
                    "last": "Ecker"
                }
            ],
            "doi": "10.1021/ci400289j",
            "firstpage": "218",
            "issn": "15499596",
            "lastpage": "229",
            "pmid": "24050383",
            "pub_year": 2014,
            "title": "Ligand and structure-based classification models for prediction of P-glycoprotein inhibitors",
            "volume": "54"
        },
        "bb0390": {
            "authors": [
                {
                    "first": "Ricardo J.",
                    "initial": "R.J.",
                    "last": "Ferreira"
                },
                {
                    "first": "Maria Jos\u00e9 U.",
                    "initial": "M.J.U.",
                    "last": "Ferreira"
                },
                {
                    "first": "Daniel J.V.A.",
                    "initial": "D.J.V.A.",
                    "last": "Dos Santos"
                }
            ],
            "doi": "10.1021/ci400195v",
            "firstpage": "1747",
            "issn": "15499596",
            "lastpage": "1760",
            "pmid": "23802684",
            "pub_year": 2013,
            "title": "Molecular docking characterizes substrate-binding sites and efflux modulation mechanisms within P-glycoprotein.",
            "volume": "53"
        },
        "bb0395": {
            "authors": [
                {
                    "first": "Ricardo J.",
                    "initial": "R.J.",
                    "last": "Ferreira"
                },
                {
                    "first": "Maria Jos\u00e9 U.",
                    "initial": "M.J.U.",
                    "last": "Ferreira"
                },
                {
                    "first": "Daniel J.V.A.",
                    "initial": "D.J.V.A.",
                    "last": "Dos Santos"
                }
            ],
            "doi": "10.1021/ct300083m",
            "firstpage": "1853",
            "issn": "15499618",
            "lastpage": "1864",
            "pub_year": 2012,
            "title": "Insights on P-glycoproteins efflux mechanism obtained by molecular dynamics simulations",
            "volume": "8"
        },
        "bb0400": {
            "authors": [
                {
                    "first": "Ricardo J.",
                    "initial": "R.J.",
                    "last": "Ferreira"
                },
                {
                    "first": "Daniel J.V.A.",
                    "initial": "D.J.V.A.",
                    "last": "Dos Santos"
                },
                {
                    "first": "Maria Jos\u00e9 U.",
                    "initial": "M.J.U.",
                    "last": "Ferreira"
                },
                {
                    "first": "Rita C.",
                    "initial": "R.C.",
                    "last": "Guedes"
                }
            ],
            "doi": "10.1021/ci200145p",
            "firstpage": "1315",
            "issn": "15499596",
            "lastpage": "1324",
            "pmid": "21604687",
            "pub_year": 2011,
            "title": "Toward a better pharmacophore description of P-glycoprotein modulators, based on macrocyclic diterpenes from euphorbia species",
            "volume": "51"
        },
        "bb0405": {
            "authors": [
                {
                    "first": "Jung Min",
                    "initial": "J.M.",
                    "last": "Kim"
                },
                {
                    "first": "Shenping",
                    "initial": "S.",
                    "last": "Wu"
                },
                {
                    "first": "Thomas M.",
                    "initial": "T.M.",
                    "last": "Tomasiak"
                },
                {
                    "first": "Claudia",
                    "initial": "C.",
                    "last": "Mergel"
                },
                {
                    "first": "Michael B.",
                    "initial": "M.B.",
                    "last": "Winter"
                },
                {
                    "first": "Sebastian B.",
                    "initial": "S.B.",
                    "last": "Stiller"
                },
                {
                    "first": "Yaneth",
                    "initial": "Y.",
                    "last": "Robles-Colmanares"
                },
                {
                    "first": "Robert M.",
                    "initial": "R.M.",
                    "last": "Stroud"
                },
                {
                    "first": "Robert",
                    "initial": "R.",
                    "last": "Tamp\u00e9"
                },
                {
                    "first": "Charles S.",
                    "initial": "C.S.",
                    "last": "Craik"
                },
                {
                    "first": "Yifan",
                    "initial": "Y.",
                    "last": "Cheng"
                }
            ],
            "doi": "10.1038/nature13872",
            "firstpage": "396",
            "issn": "00280836",
            "lastpage": "400",
            "pmid": "25363761",
            "pub_year": 2015,
            "title": "Subnanometre-resolution electron cryomicroscopy structure of a heterodimeric ABC exporter",
            "volume": "517"
        },
        "bb0410": {
            "authors": [
                {
                    "first": "Po Chao",
                    "initial": "P.C.",
                    "last": "Wen"
                },
                {
                    "first": "Brandy",
                    "initial": "B.",
                    "last": "Verhalen"
                },
                {
                    "first": "Stephan",
                    "initial": "S.",
                    "last": "Wilkens"
                },
                {
                    "first": "Hassane S.",
                    "initial": "H.S.",
                    "last": "Mchaourab"
                },
                {
                    "first": "Emad",
                    "initial": "E.",
                    "last": "Tajkhorshid"
                }
            ],
            "doi": "10.1074/jbc.M113.450114",
            "firstpage": "19211",
            "issn": "00219258",
            "lastpage": "19220",
            "pmid": "23658020",
            "pub_year": 2013,
            "title": "On the origin of large flexibility of P-glycoprotein in the inward-facing state",
            "volume": "288"
        },
        "bb0415": {
            "authors": [
                {
                    "first": "Cyril",
                    "initial": "C.",
                    "last": "Rauch"
                },
                {
                    "first": "Stuart W.",
                    "initial": "S.W.",
                    "last": "Paine"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Littlewood"
                }
            ],
            "doi": "10.1016/j.bbagen.2013.06.038",
            "firstpage": "5112",
            "issn": "03044165",
            "lastpage": "5118",
            "pmid": "23850561",
            "pub_year": 2013,
            "title": "Can long range mechanical interaction between drugs and membrane proteins define the notion of molecular promiscuity? Application to P-glycoprotein- mediated multidrug resistance (MDR)",
            "volume": "1830"
        },
        "bb0420": {
            "authors": [
                {
                    "first": "Robert A.",
                    "initial": "R.A.",
                    "last": "Copeland"
                },
                {
                    "first": "David L.",
                    "initial": "D.L.",
                    "last": "Pompliano"
                },
                {
                    "first": "Thomas D.",
                    "initial": "T.D.",
                    "last": "Meek"
                }
            ],
            "doi": "10.1038/nrd2082",
            "firstpage": "730",
            "issn": "14741776",
            "lastpage": "739",
            "pmid": "16888652",
            "pub_year": 2006,
            "title": "Drug-target residence time and its implications for lead optimization",
            "volume": "5"
        },
        "bb0425": {
            "authors": [
                {
                    "first": "Adam T.",
                    "initial": "A.T.",
                    "last": "Clay"
                },
                {
                    "first": "Frances J.",
                    "initial": "F.J.",
                    "last": "Sharom"
                }
            ],
            "doi": "10.1021/bi301532c",
            "firstpage": "343",
            "issn": "00062960",
            "lastpage": "354",
            "pmid": "23268645",
            "pub_year": 2013,
            "title": "Lipid bilayer properties control membrane partitioning, binding, and transport of P-glycoprotein substrates",
            "volume": "52"
        },
        "bb0430": {
            "authors": [
                {
                    "first": "Alexander",
                    "initial": "A.",
                    "last": "Sedykh"
                },
                {
                    "first": "Denis",
                    "initial": "D.",
                    "last": "Fourches"
                },
                {
                    "first": "Jianmin",
                    "initial": "J.",
                    "last": "Duan"
                },
                {
                    "first": "Oliver",
                    "initial": "O.",
                    "last": "Hucke"
                },
                {
                    "first": "Michel",
                    "initial": "M.",
                    "last": "Garneau"
                },
                {
                    "first": "Hao",
                    "initial": "H.",
                    "last": "Zhu"
                },
                {
                    "first": "Pierre",
                    "initial": "P.",
                    "last": "Bonneau"
                },
                {
                    "first": "Alexander",
                    "initial": "A.",
                    "last": "Tropsha"
                }
            ],
            "doi": "10.1007/s11095-012-0935-x",
            "firstpage": "996",
            "issn": "07248741",
            "lastpage": "1007",
            "pmid": "23269503",
            "pub_year": 2013,
            "title": "Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions",
            "volume": "30"
        },
        "bb0435": {
            "authors": [
                {
                    "first": "Johanna",
                    "initial": "J.",
                    "last": "Michl"
                },
                {
                    "first": "Christian",
                    "initial": "C.",
                    "last": "Scharinger"
                },
                {
                    "first": "Miriam",
                    "initial": "M.",
                    "last": "Zauner"
                },
                {
                    "first": "Siegfried",
                    "initial": "S.",
                    "last": "Kasper"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Freissmuth"
                },
                {
                    "first": "Harald H.",
                    "initial": "H.H.",
                    "last": "Sitte"
                },
                {
                    "first": "Gerhard F.",
                    "initial": "G.F.",
                    "last": "Ecker"
                },
                {
                    "first": "Lukas",
                    "initial": "L.",
                    "last": "Pezawas"
                }
            ],
            "doi": "10.1016/j.euroneuro.2014.06.013",
            "firstpage": "1463",
            "issn": "0924977X",
            "lastpage": "1474",
            "pmid": "25044049",
            "pub_year": 2014,
            "title": "A multivariate approach linking reported side effects of clinical antidepressant and antipsychotic trials to in vitro binding affinities",
            "volume": "24"
        }
    },
    "body_text": [
        {
            "endOffset": 30705,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "Subsequently, the data set was used to derive a Bayesian classification model using ECFP_6 fingerprints.",
            "startOffset": 30601,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 29738,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "refoffsets": {
                "bb0210": {
                    "endOffset": 29737,
                    "startOffset": 29733
                }
            },
            "secId": "s0035",
            "sentence": "However, detailed structure\u2013activity relationship studies showed that the hydroxy-group of the propanolamine seems not to be involved in compound\u2013transporter interaction [42].",
            "startOffset": 29563,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 45032,
            "parents": [],
            "secId": "s0055",
            "sentence": "However, experimental validation, especially with respect to prospective validation of the binding hypotheses retrieved, is mostly missing.",
            "startOffset": 44893,
            "title": "Structure-based models"
        },
        {
            "endOffset": 41337,
            "parents": [],
            "secId": "s0050",
            "sentence": "The results show the importance of overlapping binding sites for the different substrates used in the bioassays, as well as the cell line in which the transporter is expressed.",
            "startOffset": 41161,
            "title": "Data curation"
        },
        {
            "endOffset": 21773,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0020",
            "sentence": "The CFTR chloride channel is encoded by the ABCC7 gene, which is mutated in patients with cystic fibrosis.",
            "startOffset": 21667,
            "title": "Diseases related to malfunction of ABC-transporters"
        },
        {
            "endOffset": 36840,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "refoffsets": {
                "bb0250": {
                    "endOffset": 36802,
                    "startOffset": 36798
                }
            },
            "secId": "s0045",
            "sentence": "To our knowledge the largest data set for P-gp substrates/non-substrates in the public domain was compiled by Li et al. [50] (423 substrates, 300 non-substrates).",
            "startOffset": 36678,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 30600,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "refoffsets": {
                "bb0215": {
                    "endOffset": 30599,
                    "startOffset": 30595
                }
            },
            "secId": "s0035",
            "sentence": "Very recently, the hitherto largest data set for BCRP has been compiled by Montanari and Ecker, and includes 978 unique compounds extracted from 47 studies [43].",
            "startOffset": 30439,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 17470,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0010",
            "sentence": "There are numerous cases reported where co-administration of a P-gp inhibitor with a P-gp substrate considerably increased the blood levels of the latter, leading to serious side effects.",
            "startOffset": 17283,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 40726,
            "parents": [],
            "refoffsets": {
                "bb0280": {
                    "endOffset": 40668,
                    "startOffset": 40664
                },
                "bb0285": {
                    "endOffset": 40685,
                    "startOffset": 40681
                }
            },
            "secId": "s0050",
            "sentence": "Scientists wanting to build large datasets must collect and merge together such data, using databases like ChEMBL [56] and Pubchem [57], but also manual search through MEDLINE.",
            "startOffset": 40550,
            "title": "Data curation"
        },
        {
            "endOffset": 36677,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0045",
            "sentence": "Thus, the in silico models derived on basis of these data mostly use binary classification algorithms (substrate versus non substrate).",
            "startOffset": 36542,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 46389,
            "parents": [],
            "secId": "s0055",
            "sentence": "The SAR information is then used to priorities the pose cluster in order to retrieve an experimental-data-guided binding hypothesis.",
            "startOffset": 46257,
            "title": "Structure-based models"
        },
        {
            "endOffset": 32133,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "refoffsets": {
                "bb0225": {
                    "endOffset": 31907,
                    "startOffset": 31903
                }
            },
            "secId": "s0035",
            "sentence": "In case of MRP2, an ABC-transporter which also might be involved in drug\u2013drug interactions in the liver, Pedersen et al. [45] measured a set of 191 structurally diverse drugs and drug-like compounds for inhibition of MRP2-mediated transport of estradiol-17-d-glucuronide (E17G) in inside-out membrane vesicles from Sf9 cells overexpressing human MRP2.",
            "startOffset": 31782,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 48550,
            "parents": [],
            "refoffsets": {
                "bb0395": {
                    "endOffset": 48441,
                    "startOffset": 48437
                }
            },
            "secId": "s0055",
            "sentence": "In a different publication [78], the authors indeed performed 100 ns molecular dynamics simulations in order to refine their homology model.",
            "startOffset": 48410,
            "title": "Structure-based models"
        },
        {
            "endOffset": 52059,
            "parents": [],
            "secId": "s0060",
            "sentence": "Even if there would be a set of crystal structures, they still would only cover a small portion of the conformational space of the transporter.",
            "startOffset": 51916,
            "title": "Future challenges"
        },
        {
            "endOffset": 28278,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "Furthermore, shape also emerged as a crucial factor, indicating the importance of the 3D description of the molecules.",
            "startOffset": 28160,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 54922,
            "parents": [],
            "secId": "s0065",
            "sentence": "ABC-transporters represent an integral and important part of the human transportome.",
            "startOffset": 54838,
            "title": "Conclusions"
        },
        {
            "endOffset": 49928,
            "parents": [],
            "secId": "s0055",
            "sentence": "The C-family has the so-called TMD 0, which consists of 5 transmembrane helices (thus having 5 + 12 transmembrane helices) where no suitable template exists.",
            "startOffset": 49771,
            "title": "Structure-based models"
        },
        {
            "endOffset": 24328,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "bb0135": {
                    "endOffset": 24327,
                    "startOffset": 24323
                }
            },
            "secId": "s0025",
            "sentence": "A significant risk could only be detected when both P-gp and CYP3A are inhibited [27].",
            "startOffset": 24242,
            "title": "Drug\u2013drug and drug\u2013nutrient interactions"
        },
        {
            "endOffset": 55733,
            "parents": [],
            "secId": "s0065",
            "sentence": "While these models allow screening rapidly large databases of molecules to predict their substrate or inhibition properties, their interpretation remains at the level of substructures or general physico-chemical properties.",
            "startOffset": 55510,
            "title": "Conclusions"
        },
        {
            "endOffset": 40900,
            "parents": [],
            "secId": "s0050",
            "sentence": "Then merging together data becomes a challenging task.",
            "startOffset": 40846,
            "title": "Data curation"
        },
        {
            "endOffset": 14151,
            "parents": [],
            "secId": "s0005",
            "sentence": "ATP-binding cassette transporters (ABC-transporters) form a large superfamily of membrane proteins.",
            "startOffset": 14052,
            "title": "Introduction"
        },
        {
            "endOffset": 51915,
            "parents": [],
            "refoffsets": {
                "bb0410": {
                    "endOffset": 51914,
                    "startOffset": 51910
                }
            },
            "secId": "s0060",
            "sentence": "Another important issue is the flexibility inherent to P-gp and most probably to all transmembrane transporters [81].",
            "startOffset": 51798,
            "title": "Future challenges"
        },
        {
            "endOffset": 31404,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "refoffsets": {
                "bb0220": {
                    "endOffset": 31267,
                    "startOffset": 31263
                }
            },
            "secId": "s0035",
            "sentence": "In case of the human bile salt export pump (BSEP), Warner et al. [44] used a recently described in vitro membrane vesicle BSEP inhibition assay to quantify transporter inhibition for a set of 624 compounds.",
            "startOffset": 31198,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 53622,
            "parents": [],
            "secId": "s0060",
            "sentence": "As outlined in the introduction, ABC-transporters play a major role in toxicity related to drug\u2013drug interaction.",
            "startOffset": 53509,
            "title": "Future challenges"
        },
        {
            "endOffset": 47243,
            "parents": [],
            "secId": "s0055",
            "sentence": "For the authors, \u201cmodulator\u201d refers to compounds that appear to block the efflux of substrates.",
            "startOffset": 47148,
            "title": "Structure-based models"
        },
        {
            "endOffset": 46256,
            "parents": [],
            "refoffsets": {
                "bb0380": {
                    "endOffset": 46026,
                    "startOffset": 46022
                }
            },
            "secId": "s0055",
            "sentence": "Klepsch et al. [75] also built on the mouse P-gp complexed with QZ59-RRR and implemented a docking protocol which exhaustively samples the pose space of a small set of ligands which show a distinct SAR pattern followed by common scaffold clustering.",
            "startOffset": 46007,
            "title": "Structure-based models"
        },
        {
            "endOffset": 16023,
            "parents": [],
            "refoffsets": {
                "bb0020": {
                    "endOffset": 16022,
                    "startOffset": 16017
                },
                "bb0025": {
                    "endOffset": 16022,
                    "startOffset": 16017
                }
            },
            "secId": "s0005",
            "sentence": "The first representative of this new class of so-called modulators of multidrug resistance (MDR-modulators) was the calcium channel blocker verapamil [4,5].",
            "startOffset": 15867,
            "title": "Introduction"
        },
        {
            "endOffset": 30299,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "Considering the fact that MDR3 is the closest homolog to P-glycoprotein (sequence identity 75%), it seems quite unlikely that the protein is inhibited only by five compounds.",
            "startOffset": 30125,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 16374,
            "parents": [],
            "secId": "s0005",
            "sentence": "Several compounds were subject to clinical studies, but none was approved so far.",
            "startOffset": 16293,
            "title": "Introduction"
        },
        {
            "endOffset": 49100,
            "parents": [],
            "secId": "s0055",
            "sentence": "In the particular case of verapamil, the increased nonbonded interactions established, which is also shown by the modulator tariquidar, classifies the molecule as a modulator.",
            "startOffset": 48925,
            "title": "Structure-based models"
        },
        {
            "endOffset": 18442,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0010",
            "sentence": "This of course increases the complexity and renders the task of predicting bioavailability of a compound by in silico models quite a challenge.",
            "startOffset": 18299,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 30439,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "In case of BCRP, BSEP, MRP1, and MRP2, considerable progress has been made within the past few years, allowing developing in silico models.",
            "startOffset": 30300,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 23709,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0025",
            "sentence": "A selected example is the interaction of rifampin with the P-gp substrate digoxin, where patients treated with rifampin and digoxin show considerably increased digoxin levels.",
            "startOffset": 23534,
            "title": "Drug\u2013drug and drug\u2013nutrient interactions"
        },
        {
            "endOffset": 41042,
            "parents": [],
            "refoffsets": {
                "bb0290": {
                    "endOffset": 40920,
                    "startOffset": 40916
                }
            },
            "secId": "s0050",
            "sentence": "Zdrazil et al. [58], studied all bioassays from ChEMBL for P-gp inhibition and transport, when these assays reported IC50, EC50 or Ki values.",
            "startOffset": 40901,
            "title": "Data curation"
        },
        {
            "endOffset": 29384,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "However, one should bear in mind that all methods linking substructures/fragments to biological activity of course heavily depend on the presence/absence of these fragments in the data set.",
            "startOffset": 29195,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 33725,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0040",
            "sentence": "Of course, in addition to classical QSAR of local compound series and inhibitor/non-inhibitor classification models, numerous pharmacophore models have been derived.",
            "startOffset": 33560,
            "title": "Pharmacophore models for ABC-transporter inhibitors"
        },
        {
            "endOffset": 14395,
            "parents": [],
            "secId": "s0005",
            "sentence": "Generally speaking, these transporters participate in active transport, i.e. they hydrolyze ATP and use its energy to transport their substrates.",
            "startOffset": 14250,
            "title": "Introduction"
        },
        {
            "endOffset": 36541,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0045",
            "sentence": "Most commonly a polarized transport assay across a monolayer of cells overexpressing a distinct transporter is used.",
            "startOffset": 36425,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 48772,
            "parents": [],
            "secId": "s0055",
            "sentence": "Subsequent 20 ns production runs with a small set of ligands indicated that the number of interactions established between several ligands and the drug binding pocket might allow distinguishing inhibitors from substrates.",
            "startOffset": 48551,
            "title": "Structure-based models"
        },
        {
            "endOffset": 42299,
            "parents": [],
            "refoffsets": {
                "bb0305": {
                    "endOffset": 42298,
                    "startOffset": 42294
                }
            },
            "secId": "s0050",
            "sentence": "For other less studied transporters like BCRP, the picture gets worse: most of the assays use different cell lines, and little is known about the binding sites of the different substrates used in these assays [61].",
            "startOffset": 42085,
            "title": "Data curation"
        },
        {
            "endOffset": 40845,
            "parents": [],
            "secId": "s0050",
            "sentence": "Now, what if the groups measuring ABC-transporters substrate or inhibition activities each use their own assay design?",
            "startOffset": 40727,
            "title": "Data curation"
        },
        {
            "endOffset": 31782,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "The model could be further used to minimize the propensity of drug candidates to inhibit BSEP.",
            "startOffset": 31688,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 44084,
            "parents": [],
            "secId": "s0055",
            "sentence": "More recent templates available for homology modeling are provided in Table 2.",
            "startOffset": 44006,
            "title": "Structure-based models"
        },
        {
            "endOffset": 26406,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "This indicates that there are local effects (binding sites?)",
            "startOffset": 26346,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 17219,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0010",
            "sentence": "According to the multiple roles of P-gp and analogs, both substrate and inhibitor properties of compounds need to be explored.",
            "startOffset": 17093,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 47335,
            "parents": [],
            "secId": "s0055",
            "sentence": "The substrate-binding sites H and R refer to Hoechst 33342 and rhodamine-123, respectively.",
            "startOffset": 47244,
            "title": "Structure-based models"
        },
        {
            "endOffset": 39527,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0045",
            "sentence": "In summary, there are numerous models published which are able to predict inhibitors and/or substrates of the most important ABC-transporters.",
            "startOffset": 39385,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 39584,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0045",
            "sentence": "All the models described here are summarized in Table 1.",
            "startOffset": 39528,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 46504,
            "parents": [],
            "secId": "s0055",
            "sentence": "Subsequently, the docking protocol was used to classify a large set of 1608 inhibitors and non-inhibitors of P-gp.",
            "startOffset": 46390,
            "title": "Structure-based models"
        },
        {
            "endOffset": 28408,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "The authors reported an accuracy of 0.86, specificity of 0.8, sensitivity of 0.9 and Cohen's kappa of 0.7 on a true external set.",
            "startOffset": 28279,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 16129,
            "parents": [],
            "secId": "s0005",
            "sentence": "As for substrates, also in case of inhibitors P-gp is characterized by an extremely broad ligand profile.",
            "startOffset": 16024,
            "title": "Introduction"
        },
        {
            "endOffset": 43798,
            "parents": [],
            "refoffsets": {
                "bb0310": {
                    "endOffset": 43797,
                    "startOffset": 43793
                }
            },
            "secId": "s0055",
            "sentence": "However, the only human ABC-transporter crystallized so far is ABCB10 [62].",
            "startOffset": 43723,
            "title": "Structure-based models"
        },
        {
            "endOffset": 25406,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0025",
            "sentence": "These started with ligand-based approaches, which extended to structure-based studies when the first X-ray structures became available.",
            "startOffset": 25271,
            "title": "Drug\u2013drug and drug\u2013nutrient interactions"
        },
        {
            "endOffset": 14620,
            "parents": [],
            "secId": "s0005",
            "sentence": "The usual \u201ctransport unit\u201d consists of two intracellular nucleotide binding domains and two transmembrane domains.",
            "startOffset": 14506,
            "title": "Introduction"
        },
        {
            "endOffset": 20415,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "bb0080": {
                    "endOffset": 20414,
                    "startOffset": 20407
                },
                "bb0085": {
                    "endOffset": 20414,
                    "startOffset": 20407
                }
            },
            "secId": "s0015",
            "sentence": "Some of these constituents, such as bile acids, cause serious damage to hepatocytes and bile duct cells, which might lead to inflammation, fibrosis, cirrhosis, sitosterolemia, hyperbilirubinemia, cholestasis, and potentially also cancer [16,17].",
            "startOffset": 20170,
            "title": "ABC-transporters and liver toxicity"
        },
        {
            "endOffset": 31198,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "The authors report an accuracy of 0.92 and an area under the ROC curve of 0.85 in cross-validation for this naive Bayes model.",
            "startOffset": 31072,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 21255,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0015",
            "sentence": "MDR3 flops phosphatidylcholine into the bile canaliculus to protect the biliary tree from the detergent activity of bile salts.",
            "startOffset": 21128,
            "title": "ABC-transporters and liver toxicity"
        },
        {
            "endOffset": 40372,
            "parents": [],
            "secId": "s0050",
            "sentence": "Working with large datasets seems to be the way to build high quality models and derive general trends for compounds interacting with ABC-transporters.",
            "startOffset": 40221,
            "title": "Data curation"
        },
        {
            "endOffset": 30124,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "refoffsets": {
                "bb0030": {
                    "endOffset": 30079,
                    "startOffset": 30076
                }
            },
            "secId": "s0035",
            "sentence": "Thus, for MDR3, which is a phospholipid transporter expressed in the liver, only 5 compounds are retrieved by the Open PHACTS Discovery Platform [6], including taxol, vinblastine and verapamil.",
            "startOffset": 29931,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 23078,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0025",
            "sentence": "Most often, these interactions are linked to cytochrome P450-related metabolism of compounds, i.e. compound A blocks the metabolism of compound B, which increases the concentration of compound B beyond the toxic level.",
            "startOffset": 22860,
            "title": "Drug\u2013drug and drug\u2013nutrient interactions"
        },
        {
            "endOffset": 34694,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0040",
            "sentence": "Finally, 21 compounds were selected for biological testing, whereby 12 were found to significantly increase the intracellular accumulation of Rhodamine-123, a P-gp substrate.",
            "startOffset": 34520,
            "title": "Pharmacophore models for ABC-transporter inhibitors"
        },
        {
            "endOffset": 29194,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "The introduction of fingerprints remarkably improved the prediction accuracy of the models (from a sensitivity of 0.69 and specificity of 0.70 with only physicochemical descriptors on an external test set to a maximum of 0.84 in sensitivity and 0.87 in specificity on the same set but with fingerprints) and furthermore allowed to identify molecular fragments which are favorable or unfavorable for P-gp inhibition.",
            "startOffset": 28779,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 27501,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "Also in this area a number of publications appeared in the literature, and we will just summarize a few recent ones to outline the main strategies followed.",
            "startOffset": 27345,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 27203,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "refoffsets": {
                "bb0195": {
                    "endOffset": 27202,
                    "startOffset": 27198
                }
            },
            "secId": "s0035",
            "sentence": "Interestingly, also the concepts of ligand efficiency and lipophilic efficiency have to be applied in a different way than for conventional targets [39].",
            "startOffset": 27050,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 51627,
            "parents": [],
            "secId": "s0060",
            "sentence": "For ABC-transporters other than P-glycoprotein, the situation is even worse, as already the available datasets are small.",
            "startOffset": 51506,
            "title": "Future challenges"
        },
        {
            "endOffset": 34452,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0040",
            "sentence": "167 structures were found to comply with the pharmacophore model with an RMSD of < 1 \u00c5.",
            "startOffset": 34365,
            "title": "Pharmacophore models for ABC-transporter inhibitors"
        },
        {
            "endOffset": 37860,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0045",
            "sentence": "The most important structural fragments provided by the Bayesian classifier indicate that H-bond acceptors arranged in distinct spatial patterns as well as flexibility are quite essential for P-gp substrate-likeness.",
            "startOffset": 37644,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 49770,
            "parents": [],
            "secId": "s0055",
            "sentence": "This is mainly due to the fact that both mammalian structures available are from transporters belonging to the B-family (P-gp and ABCB10).",
            "startOffset": 49632,
            "title": "Structure-based models"
        },
        {
            "endOffset": 56329,
            "parents": [],
            "secId": "s0065",
            "sentence": "However, the influence of on- and off-kinetics of ligands on their efficacy as well as the multiple interplay of ABC-transporters under in vivo conditions pose additional challenges which the community will face in the near future.",
            "startOffset": 56098,
            "title": "Conclusions"
        },
        {
            "endOffset": 15687,
            "parents": [],
            "secId": "s0005",
            "sentence": "Soon after, it became evident that P-glycoprotein (P-gp) functions as an ATP-driven, transmembrane efflux pump with an extremely broad substrate specificity (polyspecificity or promiscuity).",
            "startOffset": 15497,
            "title": "Introduction"
        },
        {
            "endOffset": 16505,
            "parents": [],
            "refoffsets": {
                "bb0035": {
                    "endOffset": 16504,
                    "startOffset": 16501
                }
            },
            "secId": "s0005",
            "sentence": "This raised the question of the druggability of P-gp, and the research focus shifted towards its potential role as antitarget [7].",
            "startOffset": 16375,
            "title": "Introduction"
        },
        {
            "endOffset": 44669,
            "parents": [],
            "secId": "s0055",
            "sentence": "Furthermore, the transporters undergo a substantial conformational change when progressing through the transport cycle, which renders all structures available only snapshots of a very distinct point in the whole conformational space.",
            "startOffset": 44436,
            "title": "Structure-based models"
        },
        {
            "endOffset": 25593,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "P-glycoprotein is definitely the paradigm protein for the whole family of ABC-transporters.",
            "startOffset": 25502,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 47957,
            "parents": [],
            "secId": "s0055",
            "sentence": "Their model properly predicted 14 modulators out of 19 (74%), 20 substrates out of 32 (63%) and 2 out of 3 non-substrates.",
            "startOffset": 47835,
            "title": "Structure-based models"
        },
        {
            "endOffset": 43356,
            "parents": [],
            "secId": "s0050",
            "sentence": "That way, inter-laboratory and inter-assay differences would be immediately spotted and taken care of appropriately when merging data from different sources.",
            "startOffset": 43199,
            "title": "Data curation"
        },
        {
            "endOffset": 19342,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "bb0060": {
                    "endOffset": 19341,
                    "startOffset": 19334
                },
                "bb0065": {
                    "endOffset": 19341,
                    "startOffset": 19334
                }
            },
            "secId": "s0010",
            "sentence": "Very recent examples are provided by the group of Schinkel, who demonstrate that brain accumulation of the PARP inhibitor rucaparib and the JAK1/2 inhibitor CYT387 in mice is restricted by Abcg2 and Abcb1a/1b [12,13].",
            "startOffset": 19125,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 44006,
            "parents": [],
            "refoffsets": {
                "bb0315": {
                    "endOffset": 43939,
                    "startOffset": 43935
                }
            },
            "secId": "s0055",
            "sentence": "Nevertheless, the whole field of ABC-transporter research was inspired by the first structures being deposited in the Protein Data Bank [63], and protein homology models of P-gp immediately became available.",
            "startOffset": 43799,
            "title": "Structure-based models"
        },
        {
            "endOffset": 38566,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "refoffsets": {
                "bb0260": {
                    "endOffset": 38565,
                    "startOffset": 38561
                }
            },
            "secId": "s0045",
            "sentence": "Also for BCRP, a larger set of 263 substrates and non-substrates has been collated from literature and classified via a support vector machine [52].",
            "startOffset": 38418,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 50952,
            "parents": [],
            "secId": "s0060",
            "sentence": "This would allow benchmarking all docking studies on this structure, which definitely would increase the validity of the binding hypotheses retrieved.",
            "startOffset": 50802,
            "title": "Future challenges"
        },
        {
            "endOffset": 34519,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0040",
            "sentence": "Out of these 167 structures, 91 fulfilled the Lipinski rules of 5.",
            "startOffset": 34453,
            "title": "Pharmacophore models for ABC-transporter inhibitors"
        },
        {
            "endOffset": 52726,
            "parents": [],
            "refoffsets": {
                "bb0415": {
                    "endOffset": 52725,
                    "startOffset": 52721
                }
            },
            "secId": "s0060",
            "sentence": "However, also the composition of the membrane, its cholesterol content, as well as the behavior of the ligand in the membrane needs to be considered [82].",
            "startOffset": 52572,
            "title": "Future challenges"
        },
        {
            "endOffset": 36160,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0040",
            "sentence": "It contains two H-bond acceptor features and one hydrophobic feature.",
            "startOffset": 36091,
            "title": "Pharmacophore models for ABC-transporter inhibitors"
        },
        {
            "endOffset": 16292,
            "parents": [],
            "refoffsets": {
                "bb0030": {
                    "endOffset": 16245,
                    "startOffset": 16242
                }
            },
            "secId": "s0005",
            "sentence": "Thus, there are currently more than 5000 compounds retrieved when you search the Open PHACTS Discovery Platform [6] for compounds interacting with P-glycoprotein.",
            "startOffset": 16130,
            "title": "Introduction"
        },
        {
            "endOffset": 52445,
            "parents": [],
            "secId": "s0060",
            "sentence": "Simulating an ABC-transporter through the whole transport cycle and validating/constraining the simulation by respective biophysical and biochemical experiments seems already feasible.",
            "startOffset": 52261,
            "title": "Future challenges"
        },
        {
            "endOffset": 19851,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "bb0070": {
                    "endOffset": 19850,
                    "startOffset": 19846
                }
            },
            "secId": "s0010",
            "sentence": "A classical example in this respect is the class of antihistaminic agents: the first generation of compounds (e.g. diphenhydramine) showed remarkable CNS-related side effects, such as dizziness, whereas the 3rd generation of drugs, such as fexofenadine, is devoid of CNS side effects due to their P-gp substrate properties [14].",
            "startOffset": 19523,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 34364,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "refoffsets": {
                "bb0230": {
                    "endOffset": 34233,
                    "startOffset": 34229
                }
            },
            "secId": "s0040",
            "sentence": "Briefly, Palmeira et al. [46] created a pharmacophore model based on 26 known P-gp inhibitors from the flavonoid family, which was then used to screen DrugBank.",
            "startOffset": 34204,
            "title": "Pharmacophore models for ABC-transporter inhibitors"
        },
        {
            "endOffset": 26475,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "which translate to a distinct structure\u2013activity relationship (SAR).",
            "startOffset": 26407,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 45542,
            "parents": [],
            "secId": "s0055",
            "sentence": "As a template, mouse P-gp bound to the cyclic peptide QZ59-RRR was used.",
            "startOffset": 45470,
            "title": "Structure-based models"
        },
        {
            "endOffset": 27049,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "However, after more than 30 years of intense research, there is still no clear understanding of the molecular basis of compound\u2013transporter interaction which would translate to a set of general rules for medicinal chemists that could help them to enhance or to avoid P-gp inhibitor properties in a lead optimization program.",
            "startOffset": 26725,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 45707,
            "parents": [],
            "refoffsets": {
                "bb0375": {
                    "endOffset": 45590,
                    "startOffset": 45586
                }
            },
            "secId": "s0055",
            "sentence": "Subsequently, the dataset from Doan et al. [74] of FDA-approved drugs that included results of the monolayer efflux and CAM inhibition assays, was used for docking.",
            "startOffset": 45543,
            "title": "Structure-based models"
        },
        {
            "endOffset": 22589,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0020",
            "sentence": "Thus, modulation of their activity might be a new concept for the treatment of Alzheimer.",
            "startOffset": 22500,
            "title": "Diseases related to malfunction of ABC-transporters"
        },
        {
            "endOffset": 21127,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "bb0095": {
                    "endOffset": 21126,
                    "startOffset": 21122
                }
            },
            "secId": "s0015",
            "sentence": "For example, homozygous-null MDR3 mutations cause progressive familial intrahepatic cholestasis [19].",
            "startOffset": 21026,
            "title": "ABC-transporters and liver toxicity"
        },
        {
            "endOffset": 17997,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "bb0045": {
                    "endOffset": 17857,
                    "startOffset": 17854
                }
            },
            "secId": "s0010",
            "sentence": "However, as clearly exemplified in the Biopharmaceutics Classification System (BCS) [9], the solubility of the compounds plays also an indispensable role for assessing the final risk for transporter-related low bioavailability.",
            "startOffset": 17770,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 43541,
            "parents": [],
            "secId": "s0055",
            "sentence": "Due to the tremendous progress in the field of structural biology, structures of transmembrane transporters, including several ABC-transporters, became available.",
            "startOffset": 43379,
            "title": "Structure-based models"
        },
        {
            "endOffset": 20764,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0015",
            "sentence": "However, besides BSEP and MDR3, MRP2 (gene ABCC2) as well as P-gp and BCRP are involved.",
            "startOffset": 20676,
            "title": "ABC-transporters and liver toxicity"
        },
        {
            "endOffset": 23903,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "bb0125": {
                    "endOffset": 23902,
                    "startOffset": 23898
                }
            },
            "secId": "s0025",
            "sentence": "As the renal clearance and half-life of digoxin was not altered by rifampin, this is most probably due to an increase of the intestinal P-gp content due to an induction of P-gp expression [25].",
            "startOffset": 23710,
            "title": "Drug\u2013drug and drug\u2013nutrient interactions"
        },
        {
            "endOffset": 52571,
            "parents": [],
            "secId": "s0060",
            "sentence": "Once the system is established, this would also allow including small molecules, be it substrates, inhibitors, or modulators.",
            "startOffset": 52446,
            "title": "Future challenges"
        },
        {
            "endOffset": 53508,
            "parents": [],
            "secId": "s0060",
            "sentence": "The importance of ligand\u2013transporter interaction for prediction of toxicity and safety needs much more attention.",
            "startOffset": 53395,
            "title": "Future challenges"
        },
        {
            "endOffset": 14726,
            "parents": [],
            "secId": "s0005",
            "sentence": "The nucleotide binding domains (NBDs), usually well conserved across subfamilies, bind and hydrolyze ATP.",
            "startOffset": 14621,
            "title": "Introduction"
        },
        {
            "endOffset": 26181,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "However, the challenges in the field of ABC-transporter modeling are manifold, and the main question \u2014 what is the molecular basis for the polyspecificity \u2014 is still not solved.",
            "startOffset": 26004,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 32854,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "Interestingly, the authors also performed an analysis to examine whether inhibitors that have also been reported to be substrates, and which are thus likely to compete with E17G binding at the transport site, were structurally different from other inhibitors.",
            "startOffset": 32595,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 40443,
            "parents": [],
            "secId": "s0050",
            "sentence": "Data, however, is scarce, at least for some less studied transporters.",
            "startOffset": 40373,
            "title": "Data curation"
        },
        {
            "endOffset": 36255,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0040",
            "sentence": "The model gave a sensitivity of 78% and a specificity of 70%, with an overall accuracy of 74%.",
            "startOffset": 36161,
            "title": "Pharmacophore models for ABC-transporter inhibitors"
        },
        {
            "endOffset": 18824,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0010",
            "sentence": "Both P-gp and BCRP are highly expressed at the BBB and thus are the major functional constituents of this barrier.",
            "startOffset": 18710,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 46871,
            "parents": [],
            "refoffsets": {
                "bb0390": {
                    "endOffset": 46870,
                    "startOffset": 46866
                }
            },
            "secId": "s0055",
            "sentence": "A very comprehensive approach was used by Ferreira et al. [77].",
            "startOffset": 46808,
            "title": "Structure-based models"
        },
        {
            "endOffset": 21913,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0020",
            "sentence": "ATP-driven conformational changes open and close a gate to allow transmembrane flow of chloride anions down their electrochemical gradient.",
            "startOffset": 21774,
            "title": "Diseases related to malfunction of ABC-transporters"
        },
        {
            "endOffset": 41160,
            "parents": [],
            "secId": "s0050",
            "sentence": "Subsequently, they annotated assays according to their potential for being combined together in a large QSAR dataset.",
            "startOffset": 41043,
            "title": "Data curation"
        },
        {
            "endOffset": 28778,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "Also in their models, logP is an important contributor to distinguish inhibitors from non-inhibitors.",
            "startOffset": 28677,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 52794,
            "parents": [],
            "secId": "s0060",
            "sentence": "This opens another layer of complexity for full atomic simulations.",
            "startOffset": 52727,
            "title": "Future challenges"
        },
        {
            "endOffset": 39763,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0045",
            "sentence": "However, a set of general rules with respect to the main driving factors for ligand\u2013transporter interaction, which go beyond lipophilicity, size, and H-bonding, is still missing.",
            "startOffset": 39585,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 56697,
            "parents": [],
            "secId": "s0070",
            "sentence": "None of the funding sources took part in the study design, collection, analysis or interpretation of the data, nor in the writing and decision to submit the article for publication.",
            "startOffset": 56516,
            "title": "Funding"
        },
        {
            "endOffset": 44351,
            "parents": [],
            "secId": "s0055",
            "sentence": "Although most of these structures are in sufficient resolution to serve as templates for structure-based studies, one needs to bear in mind that there is still no protein structure cocrystallized with a classical substrate/inhibitor, such as verapamil or cyclosporin.",
            "startOffset": 44084,
            "title": "Structure-based models"
        },
        {
            "endOffset": 22499,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "bb0120": {
                    "endOffset": 22497,
                    "startOffset": 22493
                }
            },
            "secId": "s0020",
            "sentence": "Finally, there is increasing evidence that P-gp, BCRP, MRP1 (gene ABCC1) and the cholesterol transporter ABCA1 may contribute to the pathogenesis of Alzheimer's Disease (for a review see [24]).",
            "startOffset": 22306,
            "title": "Diseases related to malfunction of ABC-transporters"
        },
        {
            "endOffset": 46807,
            "parents": [],
            "refoffsets": {
                "bb0385": {
                    "endOffset": 46806,
                    "startOffset": 46802
                }
            },
            "secId": "s0055",
            "sentence": "Although the performance of the structure-based classification was considerably lower (61% for the external test set) than those obtained by Random Forest or SVM classification (73% and 75%, respectively), it shows that structure-based classification of ligands of ABC-transporter is within reach [76].",
            "startOffset": 46505,
            "title": "Structure-based models"
        },
        {
            "endOffset": 34933,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "refoffsets": {
                "bb0235": {
                    "endOffset": 34723,
                    "startOffset": 34719
                }
            },
            "secId": "s0040",
            "sentence": "Analogously, Pan et al. [47] created a pharmacophore model based on 25 BCRP inhibitors and screened the Collaborative Drug Discovery Database, which comprises 2815 FDA-approved drugs selected from all medications on the market since 1938.",
            "startOffset": 34695,
            "title": "Pharmacophore models for ABC-transporter inhibitors"
        },
        {
            "endOffset": 46996,
            "parents": [],
            "secId": "s0055",
            "sentence": "Using a previously refined structure of murine P-gp, they characterized the M-, H- and R-site by means of molecular docking.",
            "startOffset": 46872,
            "title": "Structure-based models"
        },
        {
            "endOffset": 21666,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "bb0100": {
                    "endOffset": 21665,
                    "startOffset": 21661
                }
            },
            "secId": "s0020",
            "sentence": "The paradigm example is cystic fibrosis, which is caused by mutations of the CFTR chloride channel [20].",
            "startOffset": 21562,
            "title": "Diseases related to malfunction of ABC-transporters"
        },
        {
            "endOffset": 49631,
            "parents": [],
            "secId": "s0055",
            "sentence": "However, almost all studies focus on P-gp.",
            "startOffset": 49589,
            "title": "Structure-based models"
        },
        {
            "endOffset": 24878,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "bb0160": {
                    "endOffset": 24877,
                    "startOffset": 24873
                }
            },
            "secId": "s0025",
            "sentence": "Of course, induction of protein expression \u2014 like it has been shown for St. Johns wort (Hypericum perforatum) \u2014 and cytochromes might also be a major issue, especially when considering that nuclear receptors are involved for both cytochromes and ABC-transporters [32].",
            "startOffset": 24610,
            "title": "Drug\u2013drug and drug\u2013nutrient interactions"
        },
        {
            "endOffset": 46006,
            "parents": [],
            "secId": "s0055",
            "sentence": "The results suggest that many P-gp substrates bind deeper in the cavity than the cyclic peptide in the crystal structure, and that specificity in P-gp is better understood in terms of physicochemical properties of the ligands (and the binding site), rather than being defined by specific sub-sites.",
            "startOffset": 45708,
            "title": "Structure-based models"
        },
        {
            "endOffset": 52260,
            "parents": [],
            "secId": "s0060",
            "sentence": "With the ever increasing computing power, also pushed by GPU clusters, large grids and special computer hardware, molecular dynamics simulations of transmembrane proteins in the ms range are possible.",
            "startOffset": 52060,
            "title": "Future challenges"
        },
        {
            "endOffset": 22179,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0020",
            "sentence": "Another compound developed by Vertex acts as pharmacochaperone, thus increasing the concentration of CFTR in the membrane.",
            "startOffset": 22057,
            "title": "Diseases related to malfunction of ABC-transporters"
        },
        {
            "endOffset": 53962,
            "parents": [],
            "secId": "s0060",
            "sentence": "A well established example is the interplay of P-gp and BCRP at the blood\u2013brain barrier.",
            "startOffset": 53874,
            "title": "Future challenges"
        },
        {
            "endOffset": 17092,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "bb0040": {
                    "endOffset": 17035,
                    "startOffset": 17032
                }
            },
            "secId": "s0010",
            "sentence": "Based on a proposal from the International Transporter Consortium, the FDA now recommends a standardized set of experiments to assess the likelihood of a compound to interact with P-glycoprotein and the Breast Cancer Resistance Protein (BCRP/ABCG2) [8], another member of this superfamily of ABC-transporters.",
            "startOffset": 16783,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 41497,
            "parents": [],
            "refoffsets": {
                "bb0295": {
                    "endOffset": 41365,
                    "startOffset": 41361
                }
            },
            "secId": "s0050",
            "sentence": "In another recent study [59], the authors compared IC50 values obtained across several laboratories for P-gp inhibition, each using several assay methodologies.",
            "startOffset": 41337,
            "title": "Data curation"
        },
        {
            "endOffset": 51505,
            "parents": [],
            "secId": "s0060",
            "sentence": "In case of P-glycoprotein, the size of the datasets available in the public domain is sufficient, but the use of almost 50 different assays currently does not allow combining all the data and to compile a large, high quality dataset for training the models.",
            "startOffset": 51248,
            "title": "Future challenges"
        },
        {
            "endOffset": 26003,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "refoffsets": {
                "bb0165": {
                    "endOffset": 26002,
                    "startOffset": 25995
                },
                "bb0170": {
                    "endOffset": 26002,
                    "startOffset": 25995
                },
                "bb0175": {
                    "endOffset": 26002,
                    "startOffset": 25995
                },
                "bb0180": {
                    "endOffset": 26002,
                    "startOffset": 25995
                },
                "bb0185": {
                    "endOffset": 26002,
                    "startOffset": 25995
                },
                "bb0190": {
                    "endOffset": 26002,
                    "startOffset": 25995
                }
            },
            "secId": "s0035",
            "sentence": "There are numerous reviews published which summarize these studies, and the reader is referred to a small selection for further reading [33\u201338].",
            "startOffset": 25859,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 33252,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "refoffsets": {
                "bb0275": {
                    "endOffset": 33149,
                    "startOffset": 33145
                }
            },
            "secId": "s0035",
            "sentence": "For example, Matsson and colleagues [55] used a set of 122 structurally diverse drugs to study the inhibition patterns of P-gp, BCRP, and MRP2.",
            "startOffset": 33109,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 37988,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "refoffsets": {
                "bb0255": {
                    "endOffset": 37896,
                    "startOffset": 37892
                }
            },
            "secId": "s0045",
            "sentence": "In another setting, Wang et al. [51] used a set of 332 compounds to develop a classification model using support vector machine.",
            "startOffset": 37860,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 28159,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "The final model points towards flexibility, hydrophobic surface area, and logP as main discriminating physicochemical parameters for inhibitors/non-inhibitors.",
            "startOffset": 28000,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 54826,
            "parents": [],
            "secId": "s0060",
            "sentence": "This would allow including ligand\u2013transporter interaction profiles into very early safety considerations and help to reduce late stage failures in clinical studies.",
            "startOffset": 54662,
            "title": "Future challenges"
        },
        {
            "endOffset": 42085,
            "parents": [],
            "secId": "s0050",
            "sentence": "It seems that, depending on the calculation method used, one can draw entirely different conclusions regarding the inhibition capability of compounds.",
            "startOffset": 41935,
            "title": "Data curation"
        },
        {
            "endOffset": 29930,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "While in the case of P-gp datasets of considerable size are available in the literature, for most of the other ABC-transporters there is still a lack of data for establishing in silico models.",
            "startOffset": 29738,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 32429,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "The model was capable of correctly classifying 72% of the inhibitors and 71% of the non-inhibitors in the test set.",
            "startOffset": 32314,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 53873,
            "parents": [],
            "secId": "s0060",
            "sentence": "In might well be that there are a sort of redundant backup systems, where one transporter can compensate for the functional failure of another one.",
            "startOffset": 53726,
            "title": "Future challenges"
        },
        {
            "endOffset": 17769,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0010",
            "sentence": "Compounds inducing expression of P-gp will lead to analogous results.",
            "startOffset": 17700,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 34203,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0040",
            "sentence": "However, most of the pharmacophore models derived show good capabilities in identifying new ligands with new chemical scaffolds, thus proving their utility.",
            "startOffset": 34047,
            "title": "Pharmacophore models for ABC-transporter inhibitors"
        },
        {
            "endOffset": 33108,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "Interestingly, there are also early attempts to perform selectivity profiling studies over several ABC-transporters.",
            "startOffset": 32992,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 35158,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0040",
            "sentence": "33 drugs were tested in vitro for their inhibitory effects on BCRP-mediated transport of [3H]-mitoxantrone in MCF-7/AdrVp cells, and 19 compounds were identified with significant inhibitory effect on BCRP transport function.",
            "startOffset": 34934,
            "title": "Pharmacophore models for ABC-transporter inhibitors"
        },
        {
            "endOffset": 26585,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "For each scaffold investigated, clear determinants for high and low inhibitory activity could be established.",
            "startOffset": 26476,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 43722,
            "parents": [],
            "secId": "s0055",
            "sentence": "Most of them were from prokaryotes, and only very recently structures from eukaryotic organisms were also resolved in a resolution which allows starting structure-based approaches.",
            "startOffset": 43542,
            "title": "Structure-based models"
        },
        {
            "endOffset": 15317,
            "parents": [],
            "refoffsets": {
                "bb0015": {
                    "endOffset": 15172,
                    "startOffset": 15169
                }
            },
            "secId": "s0005",
            "sentence": "It was in 1976 when Juliano and Ling [3] linked the phenomenon of anticancer multiple drug resistance to a single glycoprotein expressed in the membranes of Chinese hamster ovary cells.",
            "startOffset": 15132,
            "title": "Introduction"
        },
        {
            "endOffset": 23533,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0025",
            "sentence": "It could be that compound A blocks a transporter which is transporting compound B, thus influencing the distribution of compound B. Another scenario is that compound A induces the expression of a certain transporter, which then influences the distribution of all substrates of this transporter.",
            "startOffset": 23239,
            "title": "Drug\u2013drug and drug\u2013nutrient interactions"
        },
        {
            "endOffset": 14946,
            "parents": [],
            "secId": "s0005",
            "sentence": "These regions are usually little conserved and are responsible for the substrate specificity of the different transporters.",
            "startOffset": 14823,
            "title": "Introduction"
        },
        {
            "endOffset": 21025,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0015",
            "sentence": "One possible starting point are diseases linked to ABC-transporter mutations.",
            "startOffset": 20948,
            "title": "ABC-transporters and liver toxicity"
        },
        {
            "endOffset": 24241,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0025",
            "sentence": "However, a very recent study based on a detailed analysis of clinical drug\u2013drug interaction studies revealed that the risk for drug\u2013drug interactions caused by P-gp inhibition is quite limited.",
            "startOffset": 24048,
            "title": "Drug\u2013drug and drug\u2013nutrient interactions"
        },
        {
            "endOffset": 42665,
            "parents": [],
            "refoffsets": {
                "bb0215": {
                    "endOffset": 42664,
                    "startOffset": 42660
                }
            },
            "secId": "s0050",
            "sentence": "One solution is to compare activities reported across distinct assays, exclusively use the data for building classification models, apply a threshold for activity assay by assay and remove problematic compounds [43].",
            "startOffset": 42449,
            "title": "Data curation"
        },
        {
            "endOffset": 48924,
            "parents": [],
            "secId": "s0055",
            "sentence": "Indeed, the modulators studied consistently established a higher number of nonbonded interactions, mainly aromatic ones, when compared with substrates.",
            "startOffset": 48773,
            "title": "Structure-based models"
        },
        {
            "endOffset": 49588,
            "parents": [],
            "secId": "s0055",
            "sentence": "These studies convincingly demonstrate that structure-based modeling in the field of ABC-transporter has become a valuable tool for a deeper understanding of the molecular features driving ligand\u2013transporter interaction.",
            "startOffset": 49368,
            "title": "Structure-based models"
        },
        {
            "endOffset": 39385,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0045",
            "sentence": "This technique allowed taking into account the imbalance of the data by penalizing predictions errors made by the model on the minority class.",
            "startOffset": 39243,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 53078,
            "parents": [],
            "secId": "s0060",
            "sentence": "There is increasing evidence that the dissociation kinetics of a given drug from its target (its residence time) may be more relevant for the in vivo efficacy than its in vitro equilibrium binding constant.",
            "startOffset": 52872,
            "title": "Future challenges"
        },
        {
            "endOffset": 22859,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0025",
            "sentence": "Elderly patients are quite often subject to complex medications, and the risk of severe drug\u2013drug interactions increases with the number of drugs.",
            "startOffset": 22713,
            "title": "Drug\u2013drug and drug\u2013nutrient interactions"
        },
        {
            "endOffset": 33506,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "The inhibitor specificities of P-gp, BCRP and MRP2 were shown to be highly overlapping, and a computational model based on multivariate statistics correctly classified 80% of general ABC transporter inhibitors and non-inhibitors in an external test set.",
            "startOffset": 33253,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 22306,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "bb0105": {
                    "endOffset": 22245,
                    "startOffset": 22241
                },
                "bb0110": {
                    "endOffset": 22279,
                    "startOffset": 22275
                },
                "bb0115": {
                    "endOffset": 22305,
                    "startOffset": 22301
                }
            },
            "secId": "s0020",
            "sentence": "Other examples are the link of MRP2 to Dubin\u2013Johnson syndrome [21], of ABCA1 to Tangier disease [22], and of BCRP to gout [23].",
            "startOffset": 22179,
            "title": "Diseases related to malfunction of ABC-transporters"
        },
        {
            "endOffset": 37272,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0045",
            "sentence": "When comparing the 423 substrates with a set of 735 P-gp inhibitors, inhibitors proved to be significantly more hydrophobic than substrates while substrates tend to have more H-bond donors than inhibitors.",
            "startOffset": 37067,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 50069,
            "parents": [],
            "secId": "s0055",
            "sentence": "Even worse is the case of members of the G family (BCRP), which show a reversed order of nucleotide binding domain and transmembrane domain.",
            "startOffset": 49929,
            "title": "Structure-based models"
        },
        {
            "endOffset": 16782,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0010",
            "sentence": "This is now broadly accepted and has been also picked up by regulatory authorities.",
            "startOffset": 16699,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 26345,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "A large number of chemical scaffolds for inhibitors of P-gp have been published, and, for basically all of them, structure\u2013activity relationships could be derived.",
            "startOffset": 26182,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 38740,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0045",
            "sentence": "The final SVM model had an overall prediction accuracy of 73% for an independent test set of 40 compounds and was integrated to a free web server (http://bcrp.althotas.com).",
            "startOffset": 38567,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 33857,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0040",
            "sentence": "This is driven by the aim to understand pharmacophoric and pharmacophobic features which determine ligand\u2013transporter interactions.",
            "startOffset": 33726,
            "title": "Pharmacophore models for ABC-transporter inhibitors"
        },
        {
            "endOffset": 44435,
            "parents": [],
            "refoffsets": {
                "bb0325": {
                    "endOffset": 44434,
                    "startOffset": 44430
                }
            },
            "secId": "s0055",
            "sentence": "The only structure which includes a small molecule is the one from mouse P-gp [65].",
            "startOffset": 44352,
            "title": "Structure-based models"
        },
        {
            "endOffset": 55509,
            "parents": [],
            "secId": "s0065",
            "sentence": "In this review, we have outlined recent ligand-based models built on large datasets rather than on congeneric series.",
            "startOffset": 55392,
            "title": "Conclusions"
        },
        {
            "endOffset": 25270,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0025",
            "sentence": "Considering the multiple involvement of ABC-transporters in ADMET properties of drugs as well as their potential role as targets for treatment of multidrug resistant tumours, it is evident that numerous computational studies have been performed with the aim to predict potential compound\u2013transporter interaction and to explore the molecular basis of the polyspecificity of these transporters.",
            "startOffset": 24878,
            "title": "Drug\u2013drug and drug\u2013nutrient interactions"
        },
        {
            "endOffset": 54440,
            "parents": [],
            "secId": "s0060",
            "sentence": "Selectivity profiling, of course, is strongly linked to the availability of proper data, as one would need a matrix of a set of compounds measured at all transporters of interest.",
            "startOffset": 54261,
            "title": "Future challenges"
        },
        {
            "endOffset": 45226,
            "parents": [],
            "secId": "s0055",
            "sentence": "In this section we will thus focus on recent advances where structure-based studies were used more in the sense of virtual screening rather than providing distinct poses for selected compounds.",
            "startOffset": 45033,
            "title": "Structure-based models"
        },
        {
            "endOffset": 19990,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "bb0075": {
                    "endOffset": 19989,
                    "startOffset": 19985
                }
            },
            "secId": "s0010",
            "sentence": "In addition, as already outlined previously, drug\u2013drug interactions mediated by P-gp and BCRP are an important issue also at the BBB [15].",
            "startOffset": 19852,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 55391,
            "parents": [],
            "secId": "s0065",
            "sentence": "With the increasing accessibility of biological data and the tremendous progress of structural biology, our understanding of the molecular basis of ligand\u2013transporter interaction is progressing.",
            "startOffset": 55197,
            "title": "Conclusions"
        },
        {
            "endOffset": 17282,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0010",
            "sentence": "The latter especially is important for drug\u2013drug interactions.",
            "startOffset": 17220,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 47147,
            "parents": [],
            "secId": "s0055",
            "sentence": "The drug-binding pockets were defined as substrate- or modulator-binding sites according to the molecules that preferentially docked in each location.",
            "startOffset": 46997,
            "title": "Structure-based models"
        },
        {
            "endOffset": 15132,
            "parents": [],
            "secId": "s0005",
            "sentence": "Members of the B, C and G subfamilies are multi-drug resistance-associated transporters or associated with diseases.",
            "startOffset": 15016,
            "title": "Introduction"
        },
        {
            "endOffset": 19124,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "bb0050": {
                    "endOffset": 19123,
                    "startOffset": 19116
                },
                "bb0055": {
                    "endOffset": 19123,
                    "startOffset": 19116
                }
            },
            "secId": "s0010",
            "sentence": "Especially for the therapy of brain tumours, this is of major relevance, as most anticancer agents are substrates of P-gp and BCRP [10,11].",
            "startOffset": 18985,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 29562,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "For example, a data set which includes a series of propafenone analogs will of course point towards the importance of an aryloxypropanolamine moiety for P-gp inhibitory potency.",
            "startOffset": 29385,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 35566,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0040",
            "sentence": "Finally, the model was used to screen a virtual compound database of commercially available compounds.",
            "startOffset": 35464,
            "title": "Pharmacophore models for ABC-transporter inhibitors"
        },
        {
            "endOffset": 50801,
            "parents": [],
            "secId": "s0060",
            "sentence": "The most obvious one is the availability of an atomic resolution structure of human P-glycoprotein in complex with a prototype ligand such as verapamil.",
            "startOffset": 50649,
            "title": "Future challenges"
        },
        {
            "endOffset": 48410,
            "parents": [],
            "secId": "s0055",
            "sentence": "the substrate-binding sites may present different characteristics at different steps of the efflux mechanism, possibly interconverting the H-site and the R-site in one another, partially explaining the induced-fit and polyspecificity models proposed for Pgp substrate recognition\u201d, and point towards the importance of molecular dynamics simulations for further insights into the dynamics of the protein.",
            "startOffset": 48007,
            "title": "Structure-based models"
        },
        {
            "endOffset": 16698,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0010",
            "sentence": "With the increasing knowledge on the tissue expression and function of P-glycoprotein, its important role in absorption of drugs and drug candidates became evident.",
            "startOffset": 16534,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 25858,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "These include conventional Hansch analysis, linear and non-linear classification algorithms, pharmacophore modeling, as well as supervised and unsupervised artificial neural networks.",
            "startOffset": 25675,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 28511,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "refoffsets": {
                "bb0205": {
                    "endOffset": 28510,
                    "startOffset": 28506
                }
            },
            "secId": "s0035",
            "sentence": "Chen and colleagues compiled a large data set from literature, comprising in total 1273 compounds [41].",
            "startOffset": 28408,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 40549,
            "parents": [],
            "secId": "s0050",
            "sentence": "Typical medicinal chemistry studies report bioactivities for a small set of chemically related compounds.",
            "startOffset": 40444,
            "title": "Data curation"
        },
        {
            "endOffset": 27794,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "refoffsets": {
                "bb0200": {
                    "endOffset": 27588,
                    "startOffset": 27584
                }
            },
            "secId": "s0035",
            "sentence": "One of the groundbreaking contributions is the work of Broccatelli and colleagues [40], who used a combination of molecular field analysis, pharmacophore-based representation of the compounds, as well as physicochemical descriptors to develop both global and local models for P-gp inhibitors.",
            "startOffset": 27502,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 35745,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "refoffsets": {
                "bb0240": {
                    "endOffset": 35744,
                    "startOffset": 35740
                }
            },
            "secId": "s0040",
            "sentence": "A number of compounds found via virtual screening were tested and displayed statistically significant BSEP inhibition, ranging from 13 \u00b1 1% to 67 \u00b1 7% of control (P < 0.05) [48].",
            "startOffset": 35567,
            "title": "Pharmacophore models for ABC-transporter inhibitors"
        },
        {
            "endOffset": 15866,
            "parents": [],
            "secId": "s0005",
            "sentence": "Obviously, there were immediate attempts to develop compounds which would block the P-gp mediated efflux of anticancer drugs and thus resensitize multidrug resistant tumor cells.",
            "startOffset": 15688,
            "title": "Introduction"
        },
        {
            "endOffset": 28676,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "Their classification approach is based on recursive partitioning and naive Bayes categorization using a set of physicochemical descriptors and various fingerprints.",
            "startOffset": 28512,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 32313,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "Based on these data, a multivariate orthogonal partial least squares discriminant analysis (OPLS-DA) model that distinguishes between MRP2 inhibitors and non-inhibitors was built.",
            "startOffset": 32134,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 14822,
            "parents": [],
            "secId": "s0005",
            "sentence": "The transmembrane domains create the translocation chamber across which the substrates diffuse.",
            "startOffset": 14727,
            "title": "Introduction"
        },
        {
            "endOffset": 18094,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0010",
            "sentence": "As P-gp is an ATP-driven transporter, its transport capacity has limits and it can be saturated.",
            "startOffset": 17998,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 38243,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0045",
            "sentence": "Examination of the model based on ECFP_4 fingerprints revealed substructures such as nitrile and sulfoxide, which have a higher frequency in non-substrates than in substrates.",
            "startOffset": 38068,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 51111,
            "parents": [],
            "secId": "s0060",
            "sentence": "Nevertheless, in early drug discovery, in silico models based on machine learning will still be the main tools for prioritization of large compound libraries.",
            "startOffset": 50953,
            "title": "Future challenges"
        },
        {
            "endOffset": 54260,
            "parents": [],
            "refoffsets": {
                "bb0430": {
                    "endOffset": 54258,
                    "startOffset": 54254
                }
            },
            "secId": "s0060",
            "sentence": "There are already a few publications available which attempt to simultaneously predict the interaction of a compound of interest with several transporters (not necessarily only ABC-transporter; see e.g. [85]).",
            "startOffset": 54051,
            "title": "Future challenges"
        },
        {
            "endOffset": 21390,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0015",
            "sentence": "Thus, a misbalance of BSEP and MDR3 activity leads to toxic concentrations of bile salts either in the hepatocyte or in the bile duct.",
            "startOffset": 21256,
            "title": "ABC-transporters and liver toxicity"
        },
        {
            "endOffset": 31587,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "Relating a set of physicochemical properties of the compounds to BSEP inhibition, they showed that lipophilicity and molecular size are significantly correlated with BSEP inhibition.",
            "startOffset": 31405,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 48006,
            "parents": [],
            "secId": "s0055",
            "sentence": "However, the authors rightly conclude that \u201c....",
            "startOffset": 47958,
            "title": "Structure-based models"
        },
        {
            "endOffset": 36424,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0045",
            "sentence": "While for inhibitors a set of assays is available which leads to precise IC50 values, the case of substrates is much more complicated.",
            "startOffset": 36290,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 39065,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "refoffsets": {
                "bb0265": {
                    "endOffset": 38863,
                    "startOffset": 38859
                },
                "bb0270": {
                    "endOffset": 39006,
                    "startOffset": 39002
                }
            },
            "secId": "s0045",
            "sentence": "While finding a large dataset for MRP2 substrates and non-substrates is not an easy task to date, Pinto and colleagues [53] made use of a fuzzy dataset correlating transporter expression in cancer cell lines with the substrate capability of the tested compounds [54] to build classification models predicting MRP2 substrates.",
            "startOffset": 38740,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 53725,
            "parents": [],
            "secId": "s0060",
            "sentence": "However, due to the multiple interplay of several transporters, this requires more complex strategies.",
            "startOffset": 53623,
            "title": "Future challenges"
        },
        {
            "endOffset": 53395,
            "parents": [],
            "refoffsets": {
                "bb0425": {
                    "endOffset": 53394,
                    "startOffset": 53390
                }
            },
            "secId": "s0060",
            "sentence": "We have first evidence in our lab that this is also the case for propafenone-type inhibitors of P-gp, and also other groups already speculated on this [84].",
            "startOffset": 53239,
            "title": "Future challenges"
        },
        {
            "endOffset": 43198,
            "parents": [],
            "secId": "s0050",
            "sentence": "While agreeing on a specific assay methodology seems a bit irrealistic, a set of reference compounds for each transporter could be defined (both inactives and actives) and recommend that each laboratory willing to publish new bioactivity data must also report the bioactivities obtained on their assay for this group of reference compounds.",
            "startOffset": 42858,
            "title": "Data curation"
        },
        {
            "endOffset": 47834,
            "parents": [],
            "secId": "s0055",
            "sentence": "The classification scheme contains four main categories: (i) non-substrates, (ii) transported substrates, (iii) non-transported substrates, and (iv) modulators (Fig. 3).",
            "startOffset": 47665,
            "title": "Structure-based models"
        },
        {
            "endOffset": 18709,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0010",
            "sentence": "The BBB is characterized by tight junctions, which force all solutes to take the transcellular route.",
            "startOffset": 18608,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 36090,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "refoffsets": {
                "bb0245": {
                    "endOffset": 36020,
                    "startOffset": 36016
                }
            },
            "secId": "s0040",
            "sentence": "For MRP2, Zhang and colleagues [49] reported a pharmacophore built on nine potent and diverse inhibitors.",
            "startOffset": 35985,
            "title": "Pharmacophore models for ABC-transporter inhibitors"
        },
        {
            "endOffset": 22056,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0020",
            "sentence": "Very recently, Vertex launched a drug which potentiates the function of deltaF508 mutated CFTR and thus compensates for the impaired function.",
            "startOffset": 21914,
            "title": "Diseases related to malfunction of ABC-transporters"
        },
        {
            "endOffset": 47434,
            "parents": [],
            "secId": "s0055",
            "sentence": "Analogously, the modulator-binding (M) site was linked to the main interaction site for verapamil.",
            "startOffset": 47336,
            "title": "Structure-based models"
        },
        {
            "endOffset": 55196,
            "parents": [],
            "secId": "s0065",
            "sentence": "Furthermore, besides cytochromes, they are also involved in drug\u2013drug interactions and thus also toxicity of drugs.",
            "startOffset": 55081,
            "title": "Conclusions"
        },
        {
            "endOffset": 26724,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "They most often relate to quite basic physicochemical parameters, such as lipophilicity, H-bonding, aromatic rings, and maybe also charge.",
            "startOffset": 26586,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 42448,
            "parents": [],
            "secId": "s0050",
            "sentence": "The resulting problem is that a compound may show activity in an assay with a given substrate, but no activity in the presence of another substrate.",
            "startOffset": 42300,
            "title": "Data curation"
        },
        {
            "endOffset": 40103,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0045",
            "sentence": "Finally, when checking the original publications where the data were coming from, it becomes evident that numerous different assays are used to measure ABC-transporter inhibition.",
            "startOffset": 39924,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 18984,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0010",
            "sentence": "This has implications for the development of CNS-active drugs, as these need to cross the BBB, and thus should be devoid of P-gp and BCRP substrate properties.",
            "startOffset": 18825,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 37643,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0045",
            "sentence": "Applying a naive Bayes classifier using a set of simple molecular properties, topological descriptors, and molecular fingerprints, a classification model with very good performance was retrieved (Matthews correlation coefficient (MCC) = 0.824, prediction accuracy = 91.2% for leave 20% out cross-validation, prediction accuracy of 83.5% for a test set of 200 molecules).",
            "startOffset": 37273,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 38417,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0045",
            "sentence": "However, as already previously stated, this should be taken with caution, as substructure analysis depends on the occurrence of the respective fragments in the training set.",
            "startOffset": 38244,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 50427,
            "parents": [],
            "refoffsets": {
                "bb0405": {
                    "endOffset": 50426,
                    "startOffset": 50422
                }
            },
            "secId": "s0055",
            "sentence": "These might well use also other methods than X-ray crystallography, such as the one of TmrAB published by the Tampe group in November 2014 [80].",
            "startOffset": 50283,
            "title": "Structure-based models"
        },
        {
            "endOffset": 15496,
            "parents": [],
            "secId": "s0005",
            "sentence": "As multiple drug resistance was characterized by a decreased accumulation of the anticancer agents in the tumor cells, they named the protein P-glycoprotein (P for permeability).",
            "startOffset": 15318,
            "title": "Introduction"
        },
        {
            "endOffset": 32594,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "The coefficients in the final model show that a combination of increased lipophilicity, aromaticity, and size is a major determinant for the MRP2 inhibitory effect.",
            "startOffset": 32430,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 35463,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0040",
            "sentence": "The model recognized 9 out of 12 inhibitors, which could not be identified based on general parameters (such as molecular weight or SlogP) alone.",
            "startOffset": 35318,
            "title": "Pharmacophore models for ABC-transporter inhibitors"
        },
        {
            "endOffset": 54050,
            "parents": [],
            "secId": "s0060",
            "sentence": "But also in the liver there are numerous ABC-transporters, which have to be considered.",
            "startOffset": 53963,
            "title": "Future challenges"
        },
        {
            "endOffset": 23238,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0025",
            "sentence": "However, there are numerous reports in the literature pointing towards drug\u2013transporter interaction as additional contributor to severe drug\u2013drug interactions.",
            "startOffset": 23079,
            "title": "Drug\u2013drug and drug\u2013nutrient interactions"
        },
        {
            "endOffset": 19522,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0010",
            "sentence": "In contrast, for compounds supposed not to interact with CNS-targets, favoring P-gp substrate properties would be a versatile approach for preventing them from entering the brain.",
            "startOffset": 19343,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 30840,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "This allowed extracting important substructures, which are mostly in line with currently published SAR studies around BCRP inhibition.",
            "startOffset": 30706,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 41934,
            "parents": [],
            "refoffsets": {
                "bb0300": {
                    "endOffset": 41778,
                    "startOffset": 41774
                }
            },
            "secId": "s0050",
            "sentence": "Beyond the assay diversity and inter-laboratory variabilities, Balimane and colleagues [60] have pointed out yet another source of variability, namely the calculation of inhibition given one raw set of data measured on one assay by one laboratory.",
            "startOffset": 41687,
            "title": "Data curation"
        },
        {
            "endOffset": 24609,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "bb0140": {
                    "endOffset": 24594,
                    "startOffset": 24587
                },
                "bb0145": {
                    "endOffset": 24594,
                    "startOffset": 24587
                },
                "bb0150": {
                    "endOffset": 24594,
                    "startOffset": 24587
                },
                "bb0155": {
                    "endOffset": 24608,
                    "startOffset": 24604
                }
            },
            "secId": "s0025",
            "sentence": "One prominent example are flavonoids, which have been shown in numerous studies to interact with P-gp [28\u201330] and BCRP [31].",
            "startOffset": 24485,
            "title": "Drug\u2013drug and drug\u2013nutrient interactions"
        },
        {
            "endOffset": 21561,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0020",
            "sentence": "On a more general level, there are numerous diseases which have been linked to improper functioning ABC-transporters.",
            "startOffset": 21444,
            "title": "Diseases related to malfunction of ABC-transporters"
        },
        {
            "endOffset": 50223,
            "parents": [],
            "secId": "s0055",
            "sentence": "Although there is a considerable substrate and inhibitor overlap between P-gp and BCRP, there is no suitable template for modeling the whole transporter.",
            "startOffset": 50070,
            "title": "Structure-based models"
        },
        {
            "endOffset": 18298,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0010",
            "sentence": "P-gp becomes the limiting step only for substrates with low solubility.",
            "startOffset": 18227,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 18607,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0010",
            "sentence": "The blood\u2013brain barrier (BBB) has been recognized as a tissue/barrier where P-gp and BCRP play a major role in controlling the transcellular flux of small molecules.",
            "startOffset": 18442,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 37066,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0045",
            "sentence": "Analyzing the distributions of eight basic physicochemical properties for the substrates and non-substrates showed that molecular weight and solubility are the main factors differentiating P-gp substrates from non-substrates.",
            "startOffset": 36841,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 14249,
            "parents": [],
            "secId": "s0005",
            "sentence": "Members of the ABC-transporters can be found in all living organisms from prokaryotes to mammals.",
            "startOffset": 14152,
            "title": "Introduction"
        },
        {
            "endOffset": 49367,
            "parents": [],
            "refoffsets": {
                "bb0400": {
                    "endOffset": 49174,
                    "startOffset": 49170
                }
            },
            "secId": "s0055",
            "sentence": "This is well in accordance with a previously developed pharmacophore [79], where the ability to establish a greater number of hydrophobic interactions within the pocket is one of the major features that allows a molecule to block competitively the substrate binding.",
            "startOffset": 49101,
            "title": "Structure-based models"
        },
        {
            "endOffset": 55080,
            "parents": [],
            "secId": "s0065",
            "sentence": "Although there are only 49 genes described in humans, they fulfill important roles and are strongly linked to drug absorption, distribution, and elimination.",
            "startOffset": 54923,
            "title": "Conclusions"
        },
        {
            "endOffset": 31071,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "Basically, the number of nitrogen atoms, the aromaticity and the presence of fused aromatic heterocycles seem to favor inhibition, while the presence of sulfur atom, five-membered rings, or amide linkers seems to favor inactivity.",
            "startOffset": 30841,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 50648,
            "parents": [],
            "secId": "s0060",
            "sentence": "With respect to the prediction of drug transporter interaction, there are on our point of view several immediate issues which should be mentioned.",
            "startOffset": 50502,
            "title": "Future challenges"
        },
        {
            "endOffset": 56098,
            "parents": [],
            "secId": "s0065",
            "sentence": "Such advances have not yet been noted for other ABC-transporters, but we believe that new structures will appear in the PDB that will allow similar studies to be performed.",
            "startOffset": 55926,
            "title": "Conclusions"
        },
        {
            "endOffset": 15015,
            "parents": [],
            "refoffsets": {
                "bb0010": {
                    "endOffset": 15014,
                    "startOffset": 15011
                }
            },
            "secId": "s0005",
            "sentence": "Members of the ABCBA subfamily transport cholesterol and lipids [2].",
            "startOffset": 14947,
            "title": "Introduction"
        },
        {
            "endOffset": 27999,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "Based on a data set of 1275 compounds derived from 61 references, the authors established a workflow which combines specific (pharmacophore) and nonspecific (general physicochemical) descriptors (Fig. 2).",
            "startOffset": 27795,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 51247,
            "parents": [],
            "secId": "s0060",
            "sentence": "In silico classification models will only show high predictivity if the underlying data are of high quality and of a considerable size.",
            "startOffset": 51112,
            "title": "Future challenges"
        },
        {
            "endOffset": 24484,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0025",
            "sentence": "Therefore, they are definitely also linked to drug\u2013nutrient interactions.",
            "startOffset": 24411,
            "title": "Drug\u2013drug and drug\u2013nutrient interactions"
        },
        {
            "endOffset": 24047,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "bb0130": {
                    "endOffset": 24046,
                    "startOffset": 24042
                }
            },
            "secId": "s0025",
            "sentence": "Another well documented example is the influence of P-gp inhibitors on the distribution of HIV-1 protease inhibitors into brain and testes [26].",
            "startOffset": 23903,
            "title": "Drug\u2013drug and drug\u2013nutrient interactions"
        },
        {
            "endOffset": 20947,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0015",
            "sentence": "Thus, there are multiple possibilities for drugs and nutrients to interfere with the liver transportome, and we are just beginning to understand how this is linked to hepatotoxicity.",
            "startOffset": 20765,
            "title": "ABC-transporters and liver toxicity"
        },
        {
            "endOffset": 14505,
            "parents": [],
            "refoffsets": {
                "bb0005": {
                    "endOffset": 14490,
                    "startOffset": 14487
                }
            },
            "secId": "s0005",
            "sentence": "In humans, 49 ABC-transporters are recognized to date and belong to 7 distinct subfamilies [1], ABCA to ABCG.",
            "startOffset": 14396,
            "title": "Introduction"
        },
        {
            "endOffset": 20169,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0015",
            "sentence": "Canalicular ABC-transporters, which mediate the excretion of individual bile constituents, play a key role in bile formation and cholestasis.",
            "startOffset": 20028,
            "title": "ABC-transporters and liver toxicity"
        },
        {
            "endOffset": 53238,
            "parents": [],
            "refoffsets": {
                "bb0420": {
                    "endOffset": 53237,
                    "startOffset": 53233
                }
            },
            "secId": "s0060",
            "sentence": "Recent examples demonstrate that receptor subtype selectivity might be driven by differences in dissociation kinetics rather than by affinity differences [83].",
            "startOffset": 53079,
            "title": "Future challenges"
        },
        {
            "endOffset": 50282,
            "parents": [],
            "secId": "s0055",
            "sentence": "Thus, new structures are heavily awaited by the community.",
            "startOffset": 50224,
            "title": "Structure-based models"
        },
        {
            "endOffset": 52871,
            "parents": [],
            "secId": "s0060",
            "sentence": "Another issue linked to dynamics is the on- and off-kinetics of the ligands.",
            "startOffset": 52795,
            "title": "Future challenges"
        },
        {
            "endOffset": 18226,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0010",
            "sentence": "P-gp does not play any role in the bioavailability of highly soluble compounds, irrespective of whether they are substrates or not.",
            "startOffset": 18095,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 35317,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0040",
            "sentence": "For BSEP, a small set of 5 compounds served as basis for a pharmacophore model, which was validated against a set of 59 compounds, including registered drugs.",
            "startOffset": 35159,
            "title": "Pharmacophore models for ABC-transporter inhibitors"
        },
        {
            "endOffset": 32992,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "They were indeed on average less lipophilic than other inhibitors and also had a higher molecular weight and a larger polar surface area.",
            "startOffset": 32855,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 41686,
            "parents": [],
            "secId": "s0050",
            "sentence": "The variability range was over 20 fold for all compounds tested, and the study concluded that the most important actor was inter-laboratory variability rather than inter-assay variability.",
            "startOffset": 41498,
            "title": "Data curation"
        },
        {
            "endOffset": 27344,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "In recent years, the focus shifted to classification models for large data sets in order to allow in silico profiling of compound libraries.",
            "startOffset": 27204,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 39242,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0045",
            "sentence": "The authors reached a sensitivity of 0.77 and specificity of 0.72 in their best settings where 16 physicochemical descriptors were used to build a cost sensitive Random Forest.",
            "startOffset": 39066,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 45354,
            "parents": [],
            "refoffsets": {
                "bb0370": {
                    "endOffset": 45246,
                    "startOffset": 45242
                }
            },
            "secId": "s0055",
            "sentence": "Dolghih et al. [73] implemented a flexible receptor docking protocol for docking a set of 26 drugs known to interact with P-gp.",
            "startOffset": 45227,
            "title": "Structure-based models"
        },
        {
            "endOffset": 54661,
            "parents": [],
            "refoffsets": {
                "bb0435": {
                    "endOffset": 54660,
                    "startOffset": 54656
                }
            },
            "secId": "s0060",
            "sentence": "These models could then be further used for linking in vitro interaction profiles to in vivo effects, as recently has been shown for a set of antidepressant drugs and their side effects observed in clinical studies [86].",
            "startOffset": 54441,
            "title": "Future challenges"
        },
        {
            "endOffset": 24410,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0025",
            "sentence": "One of the major functions of ABC-transporters is the transport of natural toxins.",
            "startOffset": 24328,
            "title": "Drug\u2013drug and drug\u2013nutrient interactions"
        },
        {
            "endOffset": 31686,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "BSEP inhibitor classification by a support vector machine model leads to a total accuracy of 0.87.",
            "startOffset": 31588,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 47664,
            "parents": [],
            "secId": "s0055",
            "sentence": "Subsequently, they carried out further docking studies with molecules classified as substrates or modulators in order to retrieve a structure-based classification model with the ability to discriminate substrates from modulators.",
            "startOffset": 47435,
            "title": "Structure-based models"
        },
        {
            "endOffset": 55925,
            "parents": [],
            "secId": "s0065",
            "sentence": "On the structure-based side, the presence of crystal structures of the B subfamily allowed building high quality homology models for P-gp and a mapping of different binding sites has started.",
            "startOffset": 55734,
            "title": "Conclusions"
        },
        {
            "endOffset": 56516,
            "parents": [],
            "secId": "s0070",
            "sentence": "The research leading to this publication has received support from the Austrian Science Fund (FWF), Grant F03502 and from the University of Vienna, doctoral programme Biopromotion.",
            "startOffset": 56336,
            "title": "Funding"
        },
        {
            "endOffset": 44892,
            "parents": [],
            "refoffsets": {
                "bb0165": {
                    "endOffset": 44890,
                    "startOffset": 44874
                },
                "bb0170": {
                    "endOffset": 44890,
                    "startOffset": 44874
                },
                "bb0175": {
                    "endOffset": 44890,
                    "startOffset": 44874
                },
                "bb0185": {
                    "endOffset": 44890,
                    "startOffset": 44874
                },
                "bb0365": {
                    "endOffset": 44890,
                    "startOffset": 44874
                }
            },
            "secId": "s0055",
            "sentence": "Nevertheless, especially for P-gp, numerous docking studies of selected ligands into homology models were performed with the aim to understand the molecular determinants of binding (for reviews, see e.g. [33,34,35,72,37]).",
            "startOffset": 44670,
            "title": "Structure-based models"
        },
        {
            "endOffset": 35832,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "refoffsets": {
                "bb0180": {
                    "endOffset": 35831,
                    "startOffset": 35827
                }
            },
            "secId": "s0040",
            "sentence": "A pharmacophore for MRP1 was recently built on five diverse and potent inhibitors [36].",
            "startOffset": 35745,
            "title": "Pharmacophore models for ABC-transporter inhibitors"
        },
        {
            "endOffset": 38067,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0045",
            "sentence": "The best model (MCC = 0.73) shows a prediction accuracy of 0.88 on a test set.",
            "startOffset": 37989,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 40207,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0045",
            "sentence": "Thus, an upfront careful curation of the data seems mandatory before using them for large scale models.",
            "startOffset": 40104,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 25674,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0035",
            "sentence": "Thus, basically all methods available for ligand-based design have been applied.",
            "startOffset": 25594,
            "title": "Machine learning approaches for predicting inhibitors of ABC-transporters"
        },
        {
            "endOffset": 34046,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0040",
            "sentence": "However, due to the high structural diversity of the ligands, also pharmacophore modeling so far did not lead to a better molecular understanding of the molecular basis of polyspecificity.",
            "startOffset": 33858,
            "title": "Pharmacophore models for ABC-transporter inhibitors"
        },
        {
            "endOffset": 20675,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "refoffsets": {
                "bb0090": {
                    "endOffset": 20674,
                    "startOffset": 20670
                }
            },
            "secId": "s0015",
            "sentence": "Especially, the proper interplay (see Fig. 1) of the bile salt export pump (BSEP, gene ABCB11) with MDR3 (gene ABCB4) is critical for the formation of bile salt micelles, and inhibition of BSEP has been clearly linked to drug-induced liver injury (DILI) [18].",
            "startOffset": 20416,
            "title": "ABC-transporters and liver toxicity"
        },
        {
            "endOffset": 22712,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0025",
            "sentence": "In an aging society, drug\u2013drug interactions become an extremely important issue.",
            "startOffset": 22632,
            "title": "Drug\u2013drug and drug\u2013nutrient interactions"
        },
        {
            "endOffset": 17700,
            "parents": [
                {
                    "id": "s0005",
                    "title": "Introduction"
                }
            ],
            "secId": "s0010",
            "sentence": "Classical examples are drug\u2013drug interactions with digoxin (dronedarone, quinidine, ranolazine), loperamide (tipranavir, ritonavir), saquinavir (tipranavir, ritonavir) for P-gp and interactions with topotecan (GF120918) for BCRP.",
            "startOffset": 17471,
            "title": "ABC-transporters and ADMET"
        },
        {
            "endOffset": 35984,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0040",
            "sentence": "It is composed of 3 aromatic rings and 3 H-bond donor features and was able to retrieve 3 known inhibitors of MRP1 among a large database of 500 drugs.",
            "startOffset": 35833,
            "title": "Pharmacophore models for ABC-transporter inhibitors"
        },
        {
            "endOffset": 39923,
            "parents": [
                {
                    "id": "s0030",
                    "title": "Ligand-based models"
                }
            ],
            "secId": "s0045",
            "sentence": "Furthermore, most of the models lack proper applicability domain assessment, which renders it difficult to judge their performance in a broader chemical space.",
            "startOffset": 39764,
            "title": "Models for predicting substrates"
        },
        {
            "endOffset": 45469,
            "parents": [],
            "secId": "s0055",
            "sentence": "102 endogenous metabolites, assuming that they will not interact with the transporter, served as negative control.",
            "startOffset": 45355,
            "title": "Structure-based models"
        },
        {
            "endOffset": 50501,
            "parents": [],
            "secId": "s0060",
            "sentence": "Challenges in the field of ABC-transporter are manifold.",
            "startOffset": 50445,
            "title": "Future challenges"
        },
        {
            "endOffset": 51798,
            "parents": [],
            "secId": "s0060",
            "sentence": "For solving the issue of different assays, a transporter assay ontology combined with the definition of a set of standard reference compounds would be highly recommended.",
            "startOffset": 51628,
            "title": "Future challenges"
        },
        {
            "endOffset": 42857,
            "parents": [],
            "secId": "s0050",
            "sentence": "To alleviate the aforementioned problems related with bioactivity data in the field of transporters, one could propose some simple measures to apply and change the current habits in the field.",
            "startOffset": 42665,
            "title": "Data curation"
        }
    ],
    "docId": "S0169409X15000204",
    "metadata": {
        "asjc": [
            "3003"
        ],
        "authors": [
            {
                "email": null,
                "first": "Floriane",
                "initial": "F.",
                "last": "Montanari"
            },
            {
                "email": "gerhard.f.ecker@univie.ac.at",
                "first": "Gerhard F.",
                "initial": "G.F.",
                "last": "Ecker"
            }
        ],
        "doi": "10.1016/j.addr.2015.03.001",
        "firstpage": "17",
        "issn": "0169409X",
        "keywords": [
            "ABC transporters",
            "Bioassays",
            "Computational models",
            "Machine learning",
            "Pharmacophore modeling",
            "Transport inhibition"
        ],
        "lastpage": "26",
        "openaccess": "Full",
        "pub_year": 2015,
        "subjareas": [
            "PHAR"
        ],
        "title": "Prediction of drug-ABC-transporter interaction - Recent advances and future challenges"
    }
}